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Abstract: This review focuses on the regulation and modulation of human DNA polymerase δ (Pol δ).
The emphasis is on the mechanisms that regulate the activity and properties of Pol δ in DNA repair
and replication. The areas covered are the degradation of the p12 subunit of Pol δ, which converts
it from a heterotetramer (Pol δ4) to a heterotrimer (Pol δ3), in response to DNA damage and also
during the cell cycle. The biochemical mechanisms that lead to degradation of p12 are reviewed,
as well as the properties of Pol δ4 and Pol δ3 that provide insights into their functions in DNA
replication and repair. The second focus of the review involves the functions of two Pol δ binding
proteins, polymerase delta interaction protein 46 (PDIP46) and polymerase delta interaction protein
38 (PDIP38), both of which are multi-functional proteins. PDIP46 is a novel activator of Pol δ4, and the
impact of this function is discussed in relation to its potential roles in DNA replication. Several new
models for the roles of Pol δ3 and Pol δ4 in leading and lagging strand DNA synthesis that integrate
a role for PDIP46 are presented. PDIP38 has multiple cellular localizations including the mitochondria,
the spliceosomes and the nucleus. It has been implicated in a number of cellular functions, including
the regulation of specialized DNA polymerases, mitosis, the DNA damage response, mouse double
minute 2 homolog (Mdm2) alternative splicing and the regulation of the NADPH oxidase 4 (Nox4).
Keywords: DNA polymerase δ; PDIP46; Poldip3; PDIP38; Poldip2; DNA replication; enzyme
regulation; DNA damage response; p12 subunit; E3 ligases; cell cycle

1. Introduction
Pol δ plays a central role, together with Pol ε and Pol α/primase, as the DNA polymerases
that synthesize the daughter DNA strands at the eukaryotic replication fork. The unraveling of
the biochemistry of the mammalian DNA polymerases has posed significant experimental challenges.
Knowledge of the enzymology of the DNA polymerases is essential to an understanding of their cellular
functions. The biochemical approach is critical as pointed out by Arthur Kornberg in the context of
the discovery and unraveling of the processes of prokaryotic DNA replication [1]. In the following
review, we have focused on the regulation of Pol δ by modification of its subunit structure, and
the modulation of its functions by accessory proteins. For a broader view of regulation of Pol δ and
other polymerases, see [2,3].
1.1. Brief Historical Background
In the early 1970s, three mammalian DNA polymerases were known: Pol α, Pol β and Pol γ [4].
Pol α was considered to be the replicative polymerase, but did not possess an intrinsic or associated
30 to 50 exonuclease activity like the Escherichia coli or T4 bacteriophage DNA polymerases, where
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they function to edit or proofread misincorporated nucleotides [5–7]. Thus, the discovery of a novel
mammalian DNA polymerase with an intrinsic 30 to 50 exonuclease activity represented a major
advance. This enzyme, named Pol δ, was studied by a group of investigators at the University of Miami
in Florida, in rabbit bone marrow erythroid cells [8–11], calf thymus [12–14] and human placental
tissues [15–19]. Their approach was the rigorous isolation of the enzyme activities. This initially
resulted in the characterization of a dimeric enzyme, consisting of a catalytic subunit of 125 kDa that
harbored both the polymerase and 30 to 50 exonuclease catalytic sites and a p50 subunit. Evidence
that Pol δ was a distinct enzyme from Pol α came from their separation by purification, by their
immunochemical distinction using antibodies against Pol δ [18,20], and by the molecular cloning
of the p125 subunit [21–23]. These studies from the Miami laboratories provided a firm basis for
the identification of Pol δ as a novel proofreading DNA polymerase, and removed concerns that this
new enzyme was merely Pol α contaminated with a cellular exonuclease.
Studies of human placental [17], calf thymus [24] and HeLa Pol δ [25] led to the discovery of
a second human DNA polymerase with an intrinsic 30 50 exonuclease activity, which was named
Pol ε [26,27]. The early history of the study of Pol δ is also notable for the discovery of a factor which
stimulated its activity, and acted to modify synthesis by Pol δ from a distributive to a processive
mode [28]. This protein was identified as proliferating cell nuclear antigen (PCNA), which was
subsequently shown to be a platform for many DNA transactions [29].
These early studies defined mammalian Pol δ as having two subunits, p125 and p50. The third
and fourth accessory subunits were identified as p66/p68 [30,31] and p12 [32] (Table 1). The four
subunits of human Pol δ are encoded by the POLD1, POLD2, POLD3 and POLD4 genes. Pol δ has been
extensively studied in yeast [33]. Saccharomyces cerevisiae (S. cerevisiae) Pol δ consists of the homologs
of the p125, p50 and p68 subunits [34]. Schizosaccharomyces pombe (S. pombe) Pol δ has an additional
fourth subunit, Cdm1 [35–37], which has limited homology to p12 [32]. Molecular cloning of the p125
catalytic subunit of human Pol δ showed that the catalytic cores of the p125 subunits share greater
than 60% similarity with that of S. cerevisiae Pol3 [22,23]. Pol δ and Pol ε are members of the B family
of DNA polymerases that include T4 and Rb69 DNA polymerases.
Table 1. Subunit compositions of Pol δ.
Human

p125

p50

p68

p12

Schizosaccharomyces pombe
Saccharomyces cerevisiae

Pol3
Pol3

Cdc1
Pol31

Cdc27
Pol32

Cdm1
-

1.2. Properties of Human Pol δ4 and Its Subassemblies and the Roles of the p68 and p12 Subunits
The p68/Pol32/Cdc27 subunits of both human and yeasts possess PCNA interacting
protein-boxes (PIP-boxes) at their C-termini [30,34,38]. The p68 subunit has an extended structure,
and is highly charged, suggesting that it is flexible and thus an ideal subunit for mediating PCNA
interaction [39,40]. In S cerevisiae, the Pol32 subunit is not essential, but Cdc27 is required for viability
in S. pombe [39,40]. However, the human Pol δ p125 [41–44] and p12 [45] subunits also interact with
PCNA. The p50 subunit also interacts with PCNA [46], although this interaction is much weaker [47].
Analysis of Pol δ enzymes in which the PIP-boxes of either the p12 [45] or p68 [48] were mutated show
that both are required for full expression of activity.
The human Pol δ heterotetramer (Pol δ4), as well as its subassemblies, have been reconstituted
by their expression in the baculovirus system [49–51]. Pol δ4 has also been expressed in an E. coli
system [52]. The use of the baculovirus expression system allowed for the preparation of highly purified
Pol δ4 and its subassemblies for biochemical studies. Initial difficulties were encountered in obtaining
reproducible behaviors of the subassemblies, including that of the trimer lacking the p12 subunit [50].
This was traced to its instability during the isolation process; additionally, both the p68 and p12 subunits
are more susceptible to proteases than the p125 and p50 subunits [51]. Immunoaffinity chromatography

Genes 2017, 8, 190

3 of 30

was
as190
a key component of the purification of the Pol δ subassemblies [53]. The preparations
Genesused
2017, 8,
3 of 28
of Pol δ4 and its subassemblies were monitored for the appropriate subunit stoichiometry [51]
because
of the
possibility
of subunit[51]
lossbecause
during of
isolation
and the of
fact
these subassemblies
do exhibit
appropriate
subunit
stoichiometry
the possibility
subunit
loss during isolation
and
significant
activities.
the fact these
subassemblies do exhibit significant activities.
The
The activities
activities of
of Pol
Pol δδ and
andits
itssubassemblies
subassemblies were
were compared
compared by
by assay
assay using
using sparsely
sparsely primed
primed
poly(dA)/oligo(dT)
poly(dA)/oligo(dT) as the substrate in the
the presence
presence of
of PCNA
PCNA [51].
[51]. PCNA
PCNA does
does not
not have
have to
to be
beloaded
loaded
onto
this
linear
template
with
the
replication
factor
C
(RFC)
clamp
loader.
This
“standard”
onto this linear template with the replication factor C (RFC) clamp loader. This “standard” assay
assay
allows
quantitation of
ofPol
Polδδactivities,
activities,and
and
specific
activities
of ca.
20,000
units/mg
allows reproducible quantitation
specific
activities
of ca.
20,000
units/mg
were
were
consistently
obtained.
The relative
specific
activities
the apparent
Kd for
PCNA
binding
consistently
obtained.
The relative
specific
activities
and and
the apparent
Kd for
PCNA
binding
are
are
summarized
in
Figure
1
[51].
The
figure
also
shows
the
subunit
arrangement
of
the
p125,
p50,
summarized in Figure 1 [51]. The figure also shows the subunit arrangement of the p125, p50, p68
p68
subunits
[45].
Notably,
coreenzyme
enzymeand
andthe
the two
two trimeric
trimeric subassemblies all
andand
p12p12
subunits
[45].
Notably,
thethe
core
all possess
possess
significant
significant activities.
activities. The presence of either the p12 or the
the p68
p68 subunit
subunit is
is able
able to
to enhance
enhance PCNA
PCNA
binding
and
activity
of
the
core
enzyme
(Table
1).
However,
as
described
below,
these
subassemblies
binding and activity of the core enzyme (Table 1). However, as described below, these subassemblies
exhibit
exhibitdefects
defectsin
inassays
assaysthat
thatrequire
requirehighly
highlyprocessive
processivesynthesis.
synthesis.

Figure1.1.Relative
Relativespecific
specificactivities
activitiesand
andproliferating
proliferatingcell
cellnuclear
nuclearantigen
antigen
PCNA
binding
(nM)
Figure
PCNA
binding
(nM)
of of
PolPol
δ
δ and
subassemblies.
Data
from
[51].
and
itsits
subassemblies.
Data
from
[51].

The second type of assay that has been used is the M13 assay, in which a singly primed M13
The second type of assay that has been used is the M13 assay, in which a singly primed M13
single-stranded DNA (ssDNA) is used as the substrate. PCNA is loaded with RFC, together with
single-stranded DNA (ssDNA) is used as the substrate. PCNA is loaded with RFC, together with RPA
RPA (single stranded DNA binding protein). This assay monitors synthesis of long strands of DNA
(single stranded DNA binding protein). This assay monitors synthesis of long strands of DNA up
up to 7 kb on M13 circular DNA and has been used to demonstrate the processivity of Pol δ
to 7 kb on M13 circular DNA and has been used to demonstrate the processivity of Pol δ [51,54–56].
[51,54–56]. However, on long circular ssDNA templates, pausing can be observed where Pol δ4 has
However, on long circular ssDNA templates, pausing can be observed where Pol δ4 has difficulty
difficulty synthesizing through regions of secondary structure. In addition, it has been found that
synthesizing through regions of secondary structure. In addition, it has been found that Pol δ
Pol δ dissociates frequently during these reactions [52]. Thus, while Pol δ exhibits processivity in the
dissociates frequently during these reactions [52]. Thus, while Pol δ exhibits processivity in the
presence of PCNA, the observed processivity is not continuous (i.e., not due to a single binding
presence of PCNA, the observed processivity is not continuous (i.e., not due to a single binding event)
event) over the entire length of the M13 template. There were marked defects in the abilities of the
over the entire length of the M13 template. There were marked defects in the abilities of the Pol δ
Pol δ subassemblies to synthesize the full-length products, which could be partially compensated for
subassemblies to synthesize the full-length products, which could be partially compensated for by
by increasing the enzyme concentrations, consistent with a more frequent dissociation from the
increasing the enzyme concentrations, consistent with a more frequent dissociation from the primer
primer template [51].
template [51].
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ubiquitination and proteasomal degradation in response to DNA damage opened a new window on
the regulation of Pol δ [60]. Later, a similar process was found to take place during the G1/S
transition under the control of a key regulator of the entry to S-phase, the E3 ubiquitin ligase
CRL4Cdt2 [61]. The operational outcome of the degradation of p12 is that the Pol δ4 enzyme is
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The p12 subunit of Pol δ is selectively targeted, and similar changes are not observed for the
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other three subunits.
Loss of the p12 subunit leads to the in vivo conversion of Pol δ4 to the heterotrimer, Pol δ3.

•
•
•
•
•
•

The final observation noted above is of some importance. Prior to these studies, Pol δ4 was
considered to be the holoenzyme form, so that the first idea to come to mind was that this might be a
way to disable Pol δ4 activity. However, the Pol δ3 isolated from UV-treated cells by immunoaffinity
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The p12 subunit of Pol δ is selectively targeted, and similar changes are not observed for the other
three subunits.
Loss of the p12 subunit leads to the in vivo conversion of Pol δ4 to the heterotrimer, Pol δ3.

The final observation noted above is of some importance. Prior to these studies, Pol δ4
was considered to be the holoenzyme form, so that the first idea to come to mind was that this
might be a way to disable Pol δ4 activity. However, the Pol δ3 isolated from UV-treated cells by
immunoaffinity chromatography exhibited significant activity. Direct comparisons of Pol δ3 produced
in vivo by UV treatment with recombinant Pol δ3 showed that they had similar properties [51,60]
(see Section 1.2 for comparative properties of Pol δ4 and Pol δ3).
Thus, the question is whether Pol δ3 exhibits advantages over Pol δ4 in DNA repair. The route to
gaining insights into this possibility came from testing their functionalities utilizing highly purified
proteins in specialized assays.
2.2. Pol δ3 Exhibits Altered Behaviors from Pol δ4 in Lesion Bypass and in Extension of Mismatched Primers
that Represent a Gain of Function
In order to probe for advantages for the presence of Pol δ3 in cells subjected to genotoxic agents,
a comparison of its behavior with that of Pol δ4 was made in two contexts. First, replicative polymerases
encounter small lesions that can be bypassed by eukaryotic DNA polymerases in an error prone
manner [66,67]. Second, replicative polymerases encounter lesions that act as severe obstacles to chain
extension: these include abasic sites and thymine-thymine dimers. Model templates with small lesions
were used to study the behavior of Pol δ4 and Pol δ3 [68]; these were O6 -MeG (O6 -Methylguanine),
which is produced by alkylating agents [66], and 8-oxoG (7,8-dihydro-8-oxoguanine), which
is produced by reactive oxygen species [67]. Templates containing abasic sites and thymine-thymine
dimers were used as examples of lesions that are not readily bypassed. Pol δ3 exhibits a decreased
tendency for bypass synthesis across these templates. Pol δ3 exhibits a higher exonuclease/polymerase
ratio than Pol δ4, suggesting that it was more efficient in proofreading. Further analysis showed that
Pol δ3 is less likely to extend mismatched primers or to misincorporate wrong nucleotides in single
nucleotide incorporation assays. Overall, this study indicated that Pol δ3 exhibited behavior consistent
with it being more discriminatory than Pol δ4, i.e., of having a greater fidelity within the context of these
biochemical assays [68]. The inference drawn is that the p12 subunit exerts an influence on the intrinsic
properties of Pol δ, which could originate from effects on the polymerase or the exonuclease activities,
or both.
The kinetic [69,70] and structural bases [71,72] for the fidelity of replicative polymerases is well
understood. The rate constant for polymerization, kpol , plays a major role in the avoidance of
misincorporation of wrong nucleotides or in mutagenic bypass [69,70]. This is the so-called kinetic
barrier, in which kpol is reduced on encounter with template lesions, the binding of wrong nucleotides,
or the presence of a mismatched primer end. This increases the probability for transfer of the primer
end to the exonuclease site. The second important kinetic constant is kpol-exo , the rate at which
the primer end is translocated from the pol active site to the exonuclease site [73,74]. This transfer rate
is the rate-limiting step for the exonuclease activity in the kinetic scheme [69]. Thus, for a given
polymerase the determination of kpol and kpol-exo provides information on the polymerase and
exonuclease, respectively, while the ratio of kpol-exo to kpol may be regarded as a ratio of editing
to extension, and an index of its proofreading propensity.
Pre-steady state kinetic analysis was used to determine the kinetic constants for Pol δ4 and
Pol δ3 [58,75]. The differences between the two key kinetic constants are summarized in Figure 3,
as the ratio of their changes (Pol δ3/Pol δ4). The removal of p12 leads to a nearly five-fold decrease
in kpol , and a greater than eight-fold increase in kpol–exo , such that the ratio of editing to extension
increased by ca. 40 fold (Figure 3). Both polymerase (kpol ) and exonuclease (kpol-exo ) are affected. Thus,
by these measures, Pol δ3, compared to Pol δ4, exhibits properties of a polymerase that intrinsically
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These studies indicated that p12 exerts an influence on the proofreading functions of Pol δ, and
These studies indicated that p12 exerts an influence on the proofreading functions of Pol δ, and
that its removal to form Pol δ3 resulted in an apparent gain of function in the form of an increased
that its removal to form Pol δ3 resulted in an apparent gain of function in the form of an increased
surveillance against mutagenic synthesis.
surveillance against mutagenic synthesis.
The potential significance for the formation of Pol δ3 may be rationalized as a defense against
The potential significance for the formation of Pol δ3 may be rationalized as a defense against
mutagenic DNA synthesis in replicating cells upon genotoxic challenge. The formation of Pol δ3 in
mutagenic DNA synthesis in replicating cells upon genotoxic challenge. The formation of Pol δ3
response to DNA damage earmarks it as the likely form of Pol δ engaged in DNA repair synthesis,
in response to DNA damage earmarks it as the likely form of Pol δ engaged in DNA repair synthesis,
which in the case of UV damage, would primarily involve NER [59,76] and homologous recombination
which in the case of UV damage, would primarily involve NER [59,76] and homologous recombination
repair of DSBs. (The p12 subunit is also degraded in response to ionizing radiation [59,77]).
repair of DSBs. (The p12 subunit is also degraded in response to ionizing radiation [59,77]).
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readily than Pol δ4 [58,93]. This model is consistent with the idea that ubiquitination of PCNA and
p12 represent related cooperative events that are involved in TLS at the lesion sites.
The determination of the structure of mono-ubiquitinated PCNA (ub-PCNA) reveals that the
ubiquitins are oriented in a radially extended fashion, below the plane of the PCNA trimer, and on
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δ3 dissociates from the PCNA/DNA primer-template more readily than Pol δ4 [58,93]. This model
is consistent with the idea that ubiquitination of PCNA and p12 represent related cooperative events
that are involved in TLS at the lesion sites.
The determination of the structure of mono-ubiquitinated PCNA (ub-PCNA) reveals that
the ubiquitins are oriented in a radially extended fashion, below the plane of the PCNA trimer, and
on the opposite face of PCNA where the PIP-box binding pockets are located [93]. Additionally,
the ubiquitins displayed no contacts with PCNA beside the isopeptide linkage, and exhibit
the possibility of significant conformational flexibility. Mono-ubiquitinated PCNA was found to
lead to inhibition of the combined reactions of Pol δ4 and Fen1 (Flap endonuclease 1) activity
in Okazaki fragment processing [93]. This could potentially contribute to the UV-induced inhibition of
DNA synthesis.
2.5. Does the Plasticity of Pol δ Subunit Composition Extend to Other Subunits besides p12?
The demonstration that Pol δ is regulated by modification of its quaternary structure raises
the question of whether the other subassemblies of Pol δ could also be generated in vivo to serve
a functional role. Phenotypic analyses of the deletion of the Pol δ genes should take into account their
potential impact on the Pol δ enzyme. In the case of the p68 subunit, its deletion could potentially
result in the formation of the Pol δ3 trimer consisting of the core + p12 (Figure 1). This trimer has
activity in the standard assay which is comparable to that of Pol δ4. However, deletion of the POLD3
gene is lethal in the animal system. Conditional knockouts of POLD3 in mice have shown that it
is essential for development, and exhibits haploinsufficiency [94]. Deletion of POLD3 in B lymphocytes
led to severe replication defects and genomic instability. The mechanism was traced to a severe loss of
the p125 catalytic subunit, consistent with a loss of stability of the Pol δ complex [94]. It seems unlikely
that a regulated conversion of Pol δ4 to yield the Pol δ3’ trimer lacking p68 occurs in mammalian
cells, as this would coincide during S phase with the degradation of p12, leaving the Pol δ dimer as
the major form. However, it is noted that a temporally restricted reversible loss of p68 outside the S
phase might occur. In contrast to the effects of gene deletion in mice, DT40 chicken lymphocytes cells
in which the POLD3 gene is deleted are viable, and the cells replicate with a moderate S phase delay,
but exhibited increased sensitivity to genotoxic stress [95]. Deletion of the p68 ortholog, Pol32, is not
lethal in S. cerevisiae [34], but deletion of Cdc27 in S. pombe is lethal [38]. Apart from an impact on Pol δ,
loss of the POLD3 gene would also impact Pol ξ, which utilizes the Pol δ p50 and p68 subunits [96,97].
2.6. RNF8 Is Involved in DNA Damage-Induced p12 Degradation
The identification of the E3 ubiquitin ligase(s) that target p12 for degradation is important
in understanding how p12 degradation and the ensuing generation of Pol δ3 is integrated into
the signaling systems that comprise the DNA Damage Response (DDR) and the DNA Damage
Tolerance (DDT) pathways [63,81,85,87]. Two E3 ligases that target p12 for degradation have
been identified: RNF8 [98] and CRL4Cdt2 [61,77]. RNF8 was identified by a classical biochemical
approach [98]. An in vitro assay system was devised for the detection of the polyubiquitination of
GST-p12. Such in vitro assays require the combined actions of an E1 ubiquitin activating enzyme, an E2
ubiquitin conjugating enzyme and an E3 ubiquitin ligase. UbcH5c, which is active with a number of E3
ligases [99] was used as the E2 enzyme, and GST-p12 as the substrate. An E3 ligase fraction was purified
from HeLa cell extracts by conventional chromatographic methods. This preparation was subjected to
proteomic analysis by LC/LC/MS/MS; this yielded three peptides that were identified as sequences
from RNF8. Western blotting of the column fractions confirmed the presence of RNF8, and in vitro
assays of recombinant RNF8 showed that it had a robust activity for the ubiquitination of GST-p12.
Depletion of RNF8 confirmed that the rates of p12 degradation by UV or by alkylation with MNNG
(N-Methyl-N’-Nitro-N-Nitrosoguanidine) were significantly reduced [98].
RNF8 has a major role in orchestrating the ATM regulated DDR through the noncanonical
polyubiquitination of histone H2A [79–81,100]. The discovery that RNF8 mediates the regulation of
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Pol δ is surprising, as this raises the question as to whether RNF8 also plays significant roles in NER
and the DNA damage tolerance pathway that involves activation of translesion synthesis by PCNA
ubiquitination. RNF8 is recruited to DNA damage foci induced by UV [98,101]. RNF8, together
with UbcH5c, efficiently mono-ubiquitinates PCNA in vitro; mono-ubiquitinated PCNA (ub-PCNA)
is further polyubiquitinated via K63 isopeptide linkages by RNF8/UbcH5c and Ubc13/Uev1a [102].
Depletion of RNF8 by shRNA was found to suppress ub-PCNA formation in UV-treated A549
cells [102]. These observations suggest that RNF8 might participate in both modulation of Pol δ
and of TLS by PCNA ubiquitination [59]. The possible regulation of Pol δ and Pol η by RNF8 could be
a means for cross-talk between the ATR and ATM signaling pathways [59]. However, further work
is needed to establish what role RNF8 plays in ub-PCNA formation in vivo.
2.7. Degradation of p12 by CRL4Cdt2
Depletion of RNF8 did not completely block the degradation of p12 in response to UV damage,
indicating that more than one E3 ligase is involved. CRL4Cdt2 was found to target p12 for degradation
in response to UV, and also mediates the degradation of p12 before entry into S phase [59,61].
The CRL4Cdt2 ubiquitin ligase plays a critical role in the prevention of re-replication, as the “master
coordinator of cell cycle progression and genome stability” [103]. CRL4Cdt2 is a member of the
Cullin Ring Ligase family of E3 ubiquitin ligases and targets the licensing factors that are involved
in the assembly of the pre-replicative complex during G1, so that they are removed during the G1/S
transition [104]. The primary targets of CRL4Cdt2 are Cdt1, p21 (p21Waf1/CIP1 ) and the histone acetylase
Set8. CRL4Cdt2 recognition of its substrates depends on their possession of an extended PIP-box,
termed a PIP-degron. These PIP-degrons have a higher affinity for PCNA than PIP-boxes, and their
degradation also requires that PCNA be loaded onto DNA [105,106]. Studies in Xenopus extracts have
shown Cdt1 destruction is dependent on the initiation of DNA replication as well as Pol α, indicating
that PCNA is loaded onto the primer end [107]. CRL4Cdt2 also targets its substrates for destruction
in response to DNA damage by UV [108,109]. Both p21 [110] and Cdt1 are degraded in response to
UV damage [108,111–114].
The p12 subunit of Pol δ possesses a PIP-degron, and is a substrate for CRL4Cdt2 [61,77]. Mutation
of the PIP-degron of p12 reduces its UV-induced degradation. Depletion of either of the two isoforms
of Cul4 [115] also suppresses UV-induced p12 degradation with similar time courses as for p21 [59,61].
The NEDD8-activating enzyme (NAE) is required for Cullin ligase activity; the NAE inhibitor,
MLN4924 [116], blocks UV and IR degradation of p12 [59,77]. CRL4Cdt2 has also been shown to
be required for the UV-induced inhibition of DNA synthesis; furthermore, replication fork progression
is inhibited and is dependent on p12 degradation [77]. The latter findings provide evidence that
p12 degradation contributes to the elongation checkpoint that is a component of the intra-S phase
checkpoint [65,117].
Analysis of the cell cycle behavior of p12 and its dependence on CRL4Cdt2 were examined
in synchronized cell populations together with that of p21. These studies showed that p12 levels
were reduced during S phase and returned to basal levels during G2/M [59,61]. Depletion of CRL4Cdt2
isoforms reduced the S phase degradation of p12 [59,61]. At the same time as p12 undergoes a decrease
during the S phase, levels of the other subunits of Pol δ remain fairly constant. Thus, the degradation of
p12 by CRL4Cdt2 leads to the formation of Pol δ3 in synchrony with the S phase [59,61]. The regulation
of Pol δ3 is orchestrated by CRL4Cdt2 through common molecular mechanisms by which it controls its
other substrates, and speaks to the significance of Pol δ3 as a participant in DNA replication. The cell
cycle variations in p12, p21 and Cdt1, broadly follow comparable time courses consistent with their
regulation by CRL4Cdt2 . This has been demonstrated at the single cell level by laser scanning cytometry,
coupled with analysis of DNA replication by 5-Ethynyl-2’-deoxyuridine (EdU) labeling [118,119].
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2.8. Mechanism and Characteristics of Okazaki Fragment Processing by Pol δ4 and Pol δ3
Discontinuous DNA synthesis at the lagging strand in eukaryotes involves the synthesis of
Okazaki fragments of ca. 200 nucleotides. The process of Okazaki fragment maturation is essentially
one where they are joined to the growing lagging strand. The key elements of this process have been
characterized by biochemical reconstitution and genetic studies [33,120]. In yeast, Pol δ has been
shown to have properties that are conducive to a role in Okazaki fragment processing. One of these
is its propensity to idle at a nick, thereby allowing DNA ligase action [121]. On encounter with a 50
end of the previous Okazaki fragment, Pol δ will advance several nucleotides because of fraying of
the primer end and strand displacement, creating short flaps. These short flaps are then cleaved by Flap
endonuclease 1 (Fen1) [120,122], so that the primer ends are removed. This process is termed the short
flap pathway, and the products are predominantly mononucleotides and short oligonucleotides of
2–10 nucleotides (nt). However, Fen1 does not cleave longer flaps, and the accumulation of longer flaps
acts as a barrier to Okazaki fragment maturation and is a potential source of genomic instability. While
yeast Pol δ is able to idle at a nick, it does possess a significant ability for strand displacement [123],
so that creation of long flaps can take place. A second pathway, the “long flap pathway”, cleaves
these long flaps via the actions of Pif1 helicase and Dna2 to a length that allows their removal by
Fen1 [120,124]. The final step is ligation of the nick by DNA ligase I [125]. This can be contrasted
to the situation in prokaryotes, where the removal of the primers is performed by a nick translation
mechanism in which Pol I both extends the primer end and excises single nucleotides from the 50 end
of the prior Okazaki fragment by virtue of its 50 to 30 exonuclease activity [126].
The behavior of human Pol δ4 and Pol δ3 in the component and complete reactions of Okazaki
fragment processing were compared in a reconstituted system [59,127]. The key observations were that
Pol δ4 is proficient in strand displacement, and performs Okazaki fragment processing in a manner
similar to that of yeast Pol δ in combination with Fen1. The spectrum of flap sizes ranges from 1 to
8 nt, but is dependent on Fen1 concentration. With increasing Fen1 the product spectrum is shifted to
1–3 nt, with the mononucleotide prevailing. Pol δ3 does not perform strand displacement. With Fen1
and Pol δ3 the primary products are single nucleotides and a smaller amount of di- and trinucleotides.
The rate and nature of product formation distribution is relatively unaffected by Fen1 concentration,
supporting the proposal that mammalian Okazaki processes might involve a PCNA/Pol δ3/Fen1
complex [127], in analogy to that which has been demonstrated in the Archaeal system [128].
The question then arises, why do we need two Pol δ forms for lagging strand synthesis?
The answer may lie in the complex nature of genomic DNA. It is possible that there are template
regions that Pol δ4 is more capable than Pol δ3 of traversing. In this view, we would assign Pol δ3 as
the primary agent for Okazaki fragment synthesis and processing. The preference for the use of Pol δ3
and a nick translation mode of Okazaki fragment processing lies in the avoidance of the generation of
long flaps. Pol δ4 could also be used in Okazaki fragment processing, under circumstances discussed
below (see Section 3.4).
The large number of Okazaki fragments that needs to be generated during synthesis of the human
genome requires that the process be highly efficient, and the tendency of Pol δ to frequently dissociate
is compatible with the need for rapid recycling of Pol δ (see Section 1.2). The properties that Pol δ
displays in Okazaki fragment processing are similar to those needed for gap filling in DNA repair in
terms of the length of DNA synthesis that is required [127]. The role of PCNA may hold more importance
in this context as a platform for coordinating the reactions of Pol δ, Fen1 and DNA ligase I than its role
as a processivity factor. The kinetic constants for Pol δ4 and Pol δ3 [75] provide for an estimate or a
prediction of their processivity, based on the ratio of kpol to koff which can be approximated by kcat [129].
These provide values of 350 and 106 nt for Pol δ4 and Pol δ3 respectively. In contrast, yeast Pol δ is able
to sustain DNA synthesis in a strictly processive manner to at least 5 kb [130].
The findings that yeast Pol δ is adapted for Okazaki fragment maturation have led to extensive
studies that support a division of labor between Pol δ and Pol ε at the replication fork, where Pol δ
is the lagging strand polymerase and Pol ε is the leading strand polymerase. Much of the evidence
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for a division of labor is based on several genetic studies using mutant polymerases that allow
discrimination between leading and lagging strand DNA synthesis (reviewed in [131]). How human
Pol δ fits into this concept must now also take into account the presence of Pol δ4 and Pol δ3,
although their properties suggest that they are more adapted to lagging than leading strand synthesis
(see Sections 3.3 and 3.4 below for further discussion).
A controlled balance between Pol δ4 and Pol δ3 appears to be required in vivo for genomic stability.
Reduced expression of the POLD4 gene has been associated with lung cancer and a poor prognosis for
Genes 2017,
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3. Role of the Pol δ Binding Protein PDIP46/Poldip3 in DNA Replication and Repair
3. Role of the Pol δ Binding Protein PDIP46/Poldip3 in DNA Replication and Repair
There has been a search for accessory or auxiliary proteins that could modulate Pol δ activity
sinceThere
its initial
discovery.
novel Polorδauxiliary
interacting
proteins
previously
unknown
functions,
has been
a searchTwo
for accessory
proteins
that of
could
modulate
Pol δ activity
since
PDIP46
(Poldip2),
were discovered
by yeast two
hybrid screening
the
its
initial(Poldip3)
discovery.and
TwoPDIP38
novel Pol
δ interacting
proteins of previously
unknown
functions, with
PDIP46
p50 subunit
Pol δ as
the bait were
[134].discovered
An independent
study
tumor necrosis
α and
(Poldip3)
andofPDIP38
(Poldip2),
by yeast
two identified
hybrid screening
with the factor
p50 subunit
interleukin
6 inducible
protein
(TNFAIP1) as
a Polidentified
δ bindingtumor
protein
(PDIP1/Poldip1)
[135].
All three
of
Pol δ as the
bait [134].
An independent
study
necrosis
factor α and
interleukin
δ interacting
proteins
shareas
in acommon
the abilities
to bind
to the p50 subunit
PCNA.
The
6Pol
inducible
protein
(TNFAIP1)
Pol δ binding
protein
(PDIP1/Poldip1)
[135]. and
All three
Pol
δ
functions
of
Poldip1,
PDIP38/Poldip2
and
PDIP46/Poldip3
in
relation
to
Pol
δ
have
proven
to
be
interacting proteins share in common the abilities to bind to the p50 subunit and PCNA. The functions
enigmatic,
and they appear and
to bePDIP46/Poldip3
multifunctionalinproteins.
of
Poldip1, PDIP38/Poldip2
relation to Pol δ have proven to be enigmatic, and
PDIP46towas
re-discovered asproteins.
S6K1 Aly/REF-like target (SKAR) [136]. SKAR possesses a RRM
they appear
be multifunctional
(Figure
4) with
homology
theAly/REF-like
Aly/REF RNAtarget
binding
proteins.
latter
are involved
in
PDIP46
wasstrong
re-discovered
as to
S6K1
(SKAR)
[136].The
SKAR
possesses
a RRM
coupling
pre-mRNA
andRNA
mRNA
exportproteins.
[136]. S6K1
S6
(Figure
4)transcription
with strong with
homology
to thesplicing
Aly/REF
binding
The(ribosomal
latter are protein
involved
kinase-1)
lies
downstream
of the
mTOR and
PI3K and
signaling
pathways
that S6K1
regulate
cell growth
and
in
coupling
transcription
with
pre-mRNA
splicing
mRNA
export [136].
(ribosomal
protein
proliferation
through
nutrient,
energy
and
mitogenic
signalspathways
[137,138].that
SKAR
is a nuclear
protein,
S6
kinase-1) lies
downstream
of the
mTOR
and
PI3K signaling
regulate
cell growth
and
and is also present
the nuclear
and thesignals
EJC (exon
junction
complex)
where
it acts
to
proliferation
through in
nutrient,
energyspeckles
and mitogenic
[137,138].
SKAR
is a nuclear
protein,
and
enhance
translational
efficiency
[139–141].
Activation
of
S6K1
through
the
mTOR
and
PI3K
signaling
is also present in the nuclear speckles and the EJC (exon junction complex) where it acts to enhance
pathways leads
to phosphorylation
of PDIP46
at S383/S385.
phosphorylation
is required
for the
translational
efficiency
[139–141]. Activation
of S6K1
through This
the mTOR
and PI3K signaling
pathways
binding
of activated (phosphorylated)
S6K1 binding
to PDIP46 (Figure
4). Thisfor
leads
to their
leads
to phosphorylation
of PDIP46 at S383/S385.
This phosphorylation
is required
the binding
recruitment
to the spliceosomes
S6K1
regulates
translational
efficiency
[136,141].
siRNA
of
activated (phosphorylated)
S6K1where
binding
to PDIP46
(Figure
4). This leads
to their
recruitment
to
depletion
of S6K1where
leads to
smaller
cell size
[138], and this
effect is
also produced
siRNA depletion
the
spliceosomes
S6K1
regulates
translational
efficiency
[136,141].
siRNAby
depletion
of S6K1
of SKAR
and 4EBP1/eIF4E
Thus,
PDIP46
to translocate
activated ofS6K1
to and
the
leads
to smaller
cell size [138],[142].
and this
effect
is alsoserves
produced
by siRNA depletion
SKAR
spliceosome, [142].
subsequent
the activation
the mTOR
pathway.
Whether
which
possesses
4EBP1/eIF4E
Thus, to
PDIP46
serves to of
translocate
activated
S6K1
to the PDIP46,
spliceosome,
subsequent
anthe
Aly/REF
type
of mTOR
RNA binding
independently
affects
is
to
activation
of the
pathway.domain,
Whetheralso
PDIP46,
which possesses
an mRNA
Aly/REFmetabolism
type of RNA
unknown.
However,
PDIP46
is
also
a
binding
partner
of
enhancer
of
rudimentary
homolog
(ERH)
binding domain, also independently affects mRNA metabolism is unknown. However, PDIP46 is also
ERH
is a transcriptional
thathomolog
affects the
expression
of aisnumber
of genes in
the cell
a[143].
binding
partner
of enhancer ofregulator
rudimentary
(ERH)
[143]. ERH
a transcriptional
regulator
cycleaffects
as well
genes involved
in DNA
damage
including
and
DNA
that
the as
expression
of a number
of genes
in the
cell cycleATR,
as well
as genes
genes involved
involved in DNA
replication
[144–146].
damage including ATR, and genes involved in DNA replication [144–146].

Figure4.4.Domain
Domainmap
mapofofPDIP46/SKAR.
PDIP46/SKAR.
Figure

Recently, PDIP46 has been shown to have a role in the activation of Pol δ activity [56]. These
Recently,
PDIP46
has been
shown
a role role
in the
of Pol
Polδδactivity.
activity Its
[56].
These
effects
are reviewed
below,
and point
toto
anhave
important
foractivation
modulating
functions
effects
reviewed
below, and
point
an important
role forregulation
modulating
Pol δ as
activity.
Its functions
in thisare
regard
are consistent
with
its to
other
roles in growth
studied
the SKAR
protein.
in
this PDIP46
regard are
consistent
its other roles
in growth regulation studied as the SKAR protein.
Thus,
appears
to be awith
multifunctional
protein.
Thus, PDIP46 appears to be a multifunctional protein.
3.1. Mapping of the Interaction Sites between PDIP46 and Pol δ /PCNA Reveals that These Are Located in a
Region Separate from Those Involved in S6K1 Binding
The interaction sites of PDIP46 with PCNA and the p50 subunit were mapped to residues
71–125 and that for PCNA between residues 53 and 125 (Figure 4). The PCNA binding of PDIP46 is
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3.1. Mapping of the Interaction Sites between PDIP46 and Pol δ /PCNA Reveals that These Are Located
in a Region Separate from Those Involved in S6K1 Binding
The interaction sites of PDIP46 with PCNA and the p50 subunit were mapped to residues 71–125
and that for PCNA between residues 53 and 125 (Figure 4). The PCNA binding of PDIP46 is due to
its possession of a cluster of five APIM motifs [56]. The APIM (AlkB homologue 2 PCNA-Interacting
Motif) is a novel PCNA binding motif that was first identified in the human DNA repair enzyme
oxidative demethylase AlkB Homologue 2 (ABH2) [147]. The APIM consists of five residues with
the consensus sequence [KR]-[FYW]-[LIVA]-[LIVA]-[KR]. Seven other proteins have been shown
to have functional APIM motifs. These include Topo IIα [147], the NER protein XPA [148] and
the F-box helicase FBH1 [149] that is involved in homologous recombination. The APIM motif binds to
the same regions of PCNA as the PIP-box [150]. The separation of the locations of the PCNA/Pol δ
binding regions from the RRM/S6K1 binding domain in the C-terminus (Figure 4) is consistent with
the possibility that PDIP46 is a bi-functional protein whose two functions are harbored in two separate
structural domains [56].
3.2. Evidence that PDIP46 Is Associated with Pol δ In Vivo
There is supportive evidence that PDIP46 interacts with Pol δ in a cellular context. This has been
demonstrated by their co-immunoprecipitation and co-elution during affinity chromatography on
immobilized anti-p125 monoclonal antibody. ChIP analysis with antibody against the p125 subunit
showed that PDIP46 was present together with two components of the mammalian replisome [56].
These are Mcm2, a component of the Cdc45-MCM-GINS (CMG) helicase [151], and Ctf4, which
associates with CMG [152,153]. Thus, the ChIP data supports the idea that PDIP46 is associated with
chromatin at or near the replisome.
3.3. PDIP46 Is a Potent Activator of Pol δ
All PCNA binding proteins possess the ability to compete with Pol δ for PCNA, and therefore
can inhibit Pol δ in activity assays at sufficiently high concentrations. This was found to be the case
for PDIP46 [56] and PDIP38 [154], when assayed using poly(dA)/oligo(dT) as the substrate. More
recently, the effects of PDIP46 on Pol δ activity were examined in the M13 assays in which PCNA
is pre-loaded onto the primer end with RFC. This assay is more reflective of DNA synthesis in vivo than
the standard assay using poly(A)/oligo(dT) as the substrate (see Section 1.2). PDIP46 was revealed to
be a remarkably potent activator (ca. 10 fold) of Pol δ4 in the synthesis of the 7 kb M13 DNA, with
an apparent Kd of ca. 34 nM [56]. The mechanisms for this activation could be due to several causes.
These include an increase in processivity, possibly because PDIP46 may stabilize Pol δ binding to
PCNA by a bridging interaction, as well as by a direct activation that involves alteration of the kinetic
properties of Pol δ4.
The effects of PDIP46 were examined on model oligonucleotide templates [127] in assays that
examined primer extension and strand displacement in order to gain insights into its mechanism(s)
of action [56]. In the absence of PCNA, Pol δ4 behaves in a distributive fashion, and PDIP46 clearly
stimulates this activity. These results demonstrate that PDIP46 exerts a direct effect on Pol δ4.
In the presence of PCNA, the reactions are much faster but it was nevertheless observed that Pol δ4
activity is stimulated. Pol δ3 activity was much less affected than Pol δ4 activity. PDIP46 also stimulated
the strand displacement activity of Pol δ4 using model templates with a blocking oligonucleotide, both
in the absence and presence of PCNA. Little or no effects were observed on Pol δ3, which does not
exhibit strand displacement activity [127].
Next, the effects of PDIP46 on an oligonucleotide substrate with a hairpin/stem-loop (16-nt stem,
8-nt loop) were examined. PDIP46 stimulated Pol δ4 synthesis through the stem-loop by ca. four-fold.
While these effects are smaller than those observed with the M13 template, they explain the greatly
increased rate of accumulation of full-length products by Pol δ4 on the M13 template in the presence
of PDIP46. The M13 template may have many regions of secondary structures. Thus, there would be
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a cumulative effect on overall rates of Pol δ4 synthesis in the presence of PDIP46 [56]. PDIP46 could
act by stabilization of the Pol δ4/PCNA/DNA complex by a bridging interaction (Figure 5), as well as
by a direct activation that involves alteration of the kinetic properties of Pol δ4. The effects of PDIP46
on
Pol
δ4 8,
are
Genes
2017,
190highly relevant in the context of chromosomal replication (Section 3.4.2 below). 12 of 28
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These studies also highlight the connection between strand displacement and the ability of Pol δ
These studies also highlight the connection between strand displacement and the ability of Pol δ
to synthesize through a hairpin structure. Once Pol δ encounters the hairpin, further synthesis
to synthesize through a hairpin structure. Once Pol δ encounters the hairpin, further synthesis through
through the stem portion of the hairpin is analogous to the process of strand displacement [56].
the stem portion of the hairpin is analogous to the process of strand displacement [56]. Thus, it is not
Thus, it is not surprising that Pol δ3 exhibits minimal activity with the hairpin substrate as it does
surprising that Pol δ3 exhibits minimal activity with the hairpin substrate as it does not perform strand
not perform strand displacement activity.
displacement activity.
Mutations of PDIP46 in which all of the APIM motifs are mutated abolished the effects of
Mutations of PDIP46 in which all of the APIM motifs are mutated abolished the effects of PDIP46
PDIP46 on Pol δ4, validating the assignment of PCNA binding to this region. Deletion of the RRM
on Pol δ4, validating the assignment of PCNA binding to this region. Deletion of the RRM has no effect
has no effect on the activation of Pol δ4 by PDIP46, so that PDIP46 appears to have two independent
on the activation of Pol δ4 by PDIP46, so that PDIP46 appears to have two independent functional
functional domains [56].
domains [56].
These studies are the first to document the effects of PDIP46 on Pol δ4, and obviously raise
These studies are the first to document the effects of PDIP46 on Pol δ4, and obviously raise many
many more questions regarding its mechanism of action. In particular, kinetic studies are needed to
more questions regarding its mechanism of action. In particular, kinetic studies are needed to establish
establish whether PDIP46 has any effect on the intrinsic catalytic properties of Pol δ4. Such effects
whether PDIP46 has any effect on the intrinsic catalytic properties of Pol δ4. Such effects could also
could also involve alterations in fidelity. In addition, characterization of the range of complexity of
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secondary structures in which PDIP46 can act to facilitate Pol δ4 bypass synthesis is important in
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synthesis. This model is based on studies reviewed above in Section 2.8. In this model (Figure 6) Pol
δ3 is the default lagging strand polymerase. When regions of secondary structure which act as barriers
to Pol δ3 are encountered [56], Pol δ4 is switched with Pol δ3, together with PDIP46 (Figure 6).
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There are regions of varying template complexity in chromatin that include simple hairpins,
There are regions of varying template complexity in chromatin that include simple hairpins,
microsatellite regions [159] that contain CFS (common fragile sites), and trinucleotide repeats [160].
microsatellite regions [159] that contain CFS (common fragile sites), and trinucleotide repeats [160].
These pose potential barriers to the replicative polymerases. There has been a broadening view of
These pose potential barriers to the replicative polymerases. There has been a broadening view of
polymerase usage during normal DNA replication, e.g., the utilization of translesion polymerases,
polymerase usage during normal DNA replication, e.g., the utilization of translesion polymerases,
notably Pol κ [161,162] and Pol η in chromosomal DNA replication to augment the functions of
notably Pol κ [161,162] and Pol η in chromosomal DNA replication to augment the functions of
replicative polymerases [88,163–165]. Future characterization of the range of complexity of
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the required speed and processivity in leading strand synthesis.
In addition to a general role as a leading strand polymerase, Pol δ4/PDIP46 could act in an
analogous way as proposed above (Figure 6) in lagging strand synthesis. We propose that Pol ε may
stall at regions of secondary structure, and then is switched for Pol δ4/PDIP46 (Figure 7). The ability
of Pol ε to bypass complex template DNA regions has not been extensively studied. However, Pol ε
exhibits only minimal strand displacement activity, like Pol δ3, and has been shown to be unable to
perform strand displacement [167]. Thus, it might be predicted that Pol ε, like Pol δ3 [56], could
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The model shown in Figure 7 incorporates recent structural and functional studies of the yeast
The model shown in Figure 7 incorporates recent structural and functional studies of the yeast
replisome from the Diffley laboratory [168–171]. These studies show that the catalytic domain of Pol
replisome from the Diffley laboratory [168–171]. These studies show that the catalytic domain of Pol ε
ε is flexibly attached to its non-catalytic domain (which is engaged in complex with the CMG
is flexibly attached to its non-catalytic domain (which is engaged in complex with the CMG helicase).
helicase). The catalytic domain adopts two conformations: it is proposed that in one conformation
The catalytic domain adopts two conformations: it is proposed that in one conformation the catalytic
the catalytic domain is actively engaged with the DNA and in the other one it is disengaged
domain is actively engaged with the DNA and in the other one it is disengaged [168,169]. In the context
[168,169]. In the context of the human replisome, we envisage that encounter with replication blocks
of the human replisome, we envisage that encounter with replication blocks stalls Pol ε, leading to
stalls Pol ε, leading to the disengagement of the catalytic domain, followed by a switch to Pol
the disengagement of the catalytic domain, followed by a switch to Pol δ4/PDIP46 which performs
δ4/PDIP46 which performs the bypass synthesis (Figure 7). When Pol δ4/PDIP46 encounters the
the bypass synthesis (Figure 7). When Pol δ4/PDIP46 encounters the CMG helicase, they dissociate
CMG helicase, they dissociate and the Pol ε catalytic subunit re-engages the primer terminus.
and the Pol ε catalytic subunit re-engages the primer terminus.
The concept that the Pol ε catalytic domain can disengage from the DNA while remaining an
The concept that the Pol ε catalytic domain can disengage from the DNA while remaining
integral part of the CMG-helicase leads to a paradigm shift in our thinking of the replisome
an integral part of the CMG-helicase leads to a paradigm shift in our thinking of the replisome [168,169].
[168,169]. Thus, where previously disengagement of Pol ε would require a physical uncoupling, this
Thus, where previously disengagement of Pol ε would require a physical uncoupling, this is no longer
is no longer the case. It was proposed that Pol ε can disengage in response to replication stress, a
the case. It was proposed that Pol ε can disengage in response to replication stress, a situation that
situation that entertains the possibility of polymerase switching [168,169]. This is the situation where
Pol δ4/PDIP46 could come into play in the model shown in Figure 7.
The studies of the yeast replisome have in fact produced evidence for a switch between Pol δ
and Pol ε, and a mechanism for dealing with uncoupling events. Reconstitution of the initiation of
DNA synthesis supports a model where Pol α forms the primer; this is extended by Pol δ which then
“catches up” with the replisome to hand off the 3′ end of the leading strand to Pol ε in the advancing and
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entertains the possibility of polymerase switching [168,169]. This is the situation where Pol δ4/PDIP46
could come into play in the model shown in Figure 7.
The studies of the yeast replisome have in fact produced evidence for a switch between Pol δ and
Pol ε, and a mechanism for dealing with uncoupling events. Reconstitution of the initiation of DNA
synthesis supports a model where Pol α forms the primer; this is extended by Pol δ which then “catches
up” with the replisome to hand off the 30 end of the leading strand to Pol ε in the advancing and
uncoupled CMG-Pol ε replisome [168,169]. This is essentially a relay of polymerase handoffs where
Pol δ has the anchor role of bringing the growing primer terminus to the CMG-Pol ε. This function of
Pol δ in the yeast replisome provides a mechanism to deal with uncoupling events in a more general
context, as during replication stress [168,169]. In a sense, the view of Pol ε being able to disengage
from the primer end without dissociating from the CMG helicase allows it to have its cake and eat it.
Other studies have also shown that Pol δ dissociates once it encounters the CMG-helicase by a collision
release mechanism; this was taken as a means of selection against Pol δ at the leading strand [172,173].
However, it is noted that this would be dependent on the frequency of disengagement of Pol ε.
Once the possibility of switching of Pol δ and Pol ε is admitted, arguments against the participation
of Pol δ in leading strand synthesis based on our previous understanding of the leading strand
replisome as a tightly complexed structure are weakened. Polymerase switching involving Pol
ε suggests a far more dynamic replisome. Recent kinetic studies have indicated that human Pol
δ dissociates much more frequently than was previously thought [174]. The bacterial replisome
is the prototype of a fixed structural assembly of both leading and lagging strand polymerases with
the clamp loader. However, recent studies indicate that there is a frequent exchange of the bacterial
polymerase during replication [175]. In the case of Pol ε, a similar situation could exist in terms of
disengagement, such that uncoupling might be more frequent than expected even in the absence of
replication stress.
These ideas have significant bearing on the participation of Pol δ4 in leading strand synthesis.
There are no comparable studies that bear on the distribution of labor between Pol δ and Pol ε for
the replication of the far larger and more complex genome in human cells. However, it is noted that
replication of the SV40 genome in reconstituted systems can be achieved with Pol α and Pol δ [176,177].
One study using cross-linking and immunoprecipitation approaches, as well as immuno-electron
microscopy, has provided evidence that Pol δ and Pol ε could be functioning independently in early
and late S phase in the human system [178]. Taking into account recent views on the interplay between
Pol δ and Pol ε during leading strand synthesis in yeast discussed above, it would appear that Pol δ
may participate more extensively in leading strand synthesis than previously recognized.
There is a broader significance to the discovery that the catalytic domain of Pol ε is able to
“switch” away from the DNA. It was proposed that Pol ε could also disengage from the DNA during
replication stress [168,169]. Replication stress, broadly defined as encounter with replication barriers
due to template lesions or complex DNA structures might be addressed by similar mechanisms to
that which are well established in relation to Pol δ [88,179,180] and are based on the switching of
specialized polymerases such as the TLS polymerases. The ability of Pol ε to disengage could also
be involved in replication restart mechanisms that involve re-priming by PrimPol [181]. In the case
of re-priming, the ability of Pol ε to disengage could also open the possibility of Pol α being able to
re-prime, recapitulating the process that occurs during initiation [168,169]. These possibilities point
to a convergence and a more unified view of mechanisms that deal with replication stress at both
the leading and lagging strands of the replication fork.
There is still much to learn about the functions of PDIP46 in DNA replication. In addition to
further biochemical analyses of the mechanisms by which PDIP46 affects Pol δ4, are questions as
to whether PDIP46 functions are regulated by the mTOR pathway or by DNA damage signaling
pathways. The functions of PDIP46 as SKAR indicates that it is a bifunctional protein, pointing
to a need for structural studies, as well as careful dissection of the two functions, to allow design
of appropriate mutations that selectively target its effects on Pol δ. The proposed roles of PDIP46
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in DNA replication would be expected to yield phenotypes in a cellular context when its functions
are disabled that reflect disturbances in DNA replication and genomic stability. Recent studies of
genetic alterations in cells derived from high-risk neuroblastoma tissues have identified a group of
genes whose alterations in copy number resulted in high tumorigenic capacity. The PDIP46 gene
(POLDIP3) was one of six genes whose lowered expression was correlated with decreased overall and
relapse free survival in a cohort of 88 patients [182]. Along with this, immunohistochemical tissue
staining reveals a pattern of lowered expression in over 20 of the most common cancers (Human
Protein Atlas, [183]). The catalogue of somatic mutations in cancer (COSMIC) database also showed
that significant up- or down-regulation of POLDIP3 as being associated with various cancers as
well as a number of mutations [184]. This provides some evidence that PDIP46 function is involved
in maintenance of genomic stability.
4. PDIP38/Poldip2: A Multi-Faceted Protein
Recombinant mature PDIP38 at high concentrations (micromolar) inhibit Pol δ activity, an effect
likely due to competition for PCNA that is unlikely to be physiologically relevant [154]. Thus despite
its binding to Pol δ, the effects of PDIP38 on Pol δ, if any, are as yet not well defined. Studies reviewed
below implicate PDIP38 in a number of cellular processes that are diverse, and further complicated by
its localization to multiple subcellular organelles and structures, as well as its association with multiple
protein partners including a transmembrane enzyme.
4.1. PDIP38 Is a Mitochondrial Protein with Multiple Subcellular Localizations
Analysis of the subcellular localization of PDIP38 revealed that it is primarily a mitochondrial
protein. PDIP38 possesses a mitochondrial targeting site located in the N-terminal 30 amino
acid residues, and cleavage sites [185] for mitochondrial processing peptidase and mitochondrial
intermediate peptidase [154]. The N-terminal 50 residues are efficiently removed to yield a 38 kDa
protein rather than the expected 42 kDa precursor. Cell fractionation experiments indicated that the
bulk of the PDIP38 in cells was in a mitochondrial pellet, and resistant to proteinase K digestion
until the membranes were solubilized with Triton X-100; a smaller amount was present in the nuclear
fraction. Immunofluorescence studies of endogenous PDIP38 as well as of ectopically expressed
C-terminally-tagged EGFP constructs showed that they are localized to the mitochondria [154]. Similar
fractionation and immunofluorescence studies in two other studies confirmed these findings with
the further indication that PDIP38 is present in the mitochondria matrix [186,187]. PDIP38 was found
to associate with mitochondrial single stranded binding protein (mt SSB) and with the mitochondrial
DNA nucleoid/mitochromosome [186,187]. The functions of PDIP38 in mitochondria are still unclear;
in addition to potential effects on mitochondrial DNA replication, its depletion affects mitochondrial
morphology [187], raising a question of whether the effects of its depletion also impacts mitochondrial
energy metabolism.
There are conflicting reports on the subcellular localization of PDIP38. PDIP38 was found to be
an interacting protein for CEACAM1, a cell adhesion receptor [188]. Analysis of its subcellular
localization using peptide directed antibodies showed that the bulk of the PDIP38 is present
in the cytoplasm, but does not co-localize with mitochondrial markers, a result contradictory to
the studies described above. The basis of this difference regarding mitochondrial localization from
those reported above [154] are unknown, although this could be due to differences in the antibodies
used or the fixing of the cells. However, these studies did show significant evidence for PDIP38
in the nuclei. PDIP38 was dynamically localized to the cell surface membranes and the nuclei under
influence of CEACAM1 [188]. Further analysis showed that PDIP38 is localized to the mitotic spindle.
siRNA depletion of PDIP38 or microinjection of PDIP38 antibodies was associated with the appearance
of aberrant spindle formation, chromosome segregation, as well as multinucleate cells [189].
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4.2. Interaction of PDIP38/Poldip2 with Pol η and Other TLS Polymerases: Involvement of PDIP38 in
the DNA Damage Tolerance Pathway
PDIP38 was found to interact directly with Pol η by a yeast two-hybrid screen with Pol η as
the bait. Depletion of Pol η, PDIP38, or both, led to similar degrees of increased sensitivity to UV
in cell survival assays. This suggested that PDIP38 plays an integral role in Pol η function [190].
The molecular mechanisms of the connections between PDIP38 and Pol η remain to be elucidated, but
it has been suggested that PDIP38 might be a mediator in the switching process between Pol δ and
Pol η [190]. In this context, PDIP38 might act to facilitate the recruitment of Pol η to Pol δ stalled at
UV lesions. PDIP38 was also found to bind to the specialized polymerases Rev1 and Pol ξ (through
interaction with the Rev7 subunit) [190]. These findings indicate that PDIP38 might be involved
in the functions of other specialized DNA polymerases. The functional effects of PDIP38 on Rev1 and
Pol ξ have not been reported.
Analysis of the effects of PDIP38 on five different DNA polymerases (Pols δ, η, ι, λ and β) showed
that only the activities of Pol δ, Pol η and Pol λ were affected, consistent with the finding that Pol λ also
physically interacts with PDIP38 [191]. PDIP38 (as the full-length protein) stimulated the processivity
and catalytic activities of Pol η and Pol λ at low nanomolar concentrations on oligonucleotide templates
containing lesions that included 8-oxoG, abasic sites and thymine-thymine dimers [191]. Additionally,
the error-free bypass of 8-oxoG was increased, and a stimulatory effect on Pol δ was also found.
Pol λ [192–194] participates in base excision repair of oxidative damage of guanine bases, as well as
in a form of nonhomologous end joining repair of DSBs [193,195–197]. It was also demonstrated that
depletion of PDIP38 led to an increase in the sensitivity of cultured cells to oxidizing agents [191].
Recently, a sixth polymerase was added to the list of PDIP38 binding proteins, this being PrimPol [198].
PrimPol is a member of the archaeo-eukaryotic primase (AEP) superfamily and exhibits primase,
polymerase as well as translesion polymerase activities, and has emerged as having the ability to
reprime DNA replication at sites of replication stress [181]. The effects of PDIP38 on PrimPol mirror
those found for Pol η and Pol λ, viz., activation, increased processivity and fidelity for bypass of
8-oxoG. Depletion of either PDIP38 or PrimPol (or both) gave rise to replication defects (decrease
in replication fork rates) in response to UV damage, suggesting that they are linked in the same
pathway in vivo [198].
That PDIP38 is capable of interactions with a diverse group of polymerases raises interesting
questions as to how this is achieved. Two similar short amino-acid sequences that are involved
in PDIP38 binding were identified in Pol η [190] and in PrimPol [198]. An N-terminal sequence within
the mitochondrial targeting sequence of PDIP38 was found to be a binding region for PrimPol. Full
length PDIP38, but not the processed form, was able to activate PrimPol and Pol η [198]. These findings
raise the question of whether levels of the unprocessed form in the nuclei would be sufficient to achieve
functional concentrations in vivo, as most of the cellular PDIP38 is in the processed form [154].
The broad versatility of PDIP38 in the regulation of these polymerases, all of which are involved
in the relief of replication stress, makes the elucidation of its structure and the location of its interaction
sites an important goal. Furthermore, the apparently wide reach of PDIP38 in modulating activities of
polymerases involved in translesion synthesis and relief of replicative stress indicates that it is likely
to be under the control of the DNA damage tolerance regulatory pathways, notably those under
the apical ATR kinase.
4.3. PDIP38 Responds to Genotoxic and Transcriptional Stress by Translocation to the Spliceosomes/Nuclear
Speckles and Is Involved in Regulation of the Alternative Splicing of Mdm2
The potential involvement of PDIP38 in Pol η function suggests that it should be recruited to
UV damage foci [190]. Using the technique of UV exposure through UV-opaque polycarbonate filters
with 5 or 10 µm pores to create local areas of irradiation [84], it was observed that PDIP38 was not
recruited to these DNA damage foci, in contrast to Pol η and PCNA [199]. This finding does not negate
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the proposal that PDIP38 is involved in Pol η recruitment [190], since the mechanism is unknown and
might involve a transient association of PDIP38 to DNA damage sites.
Examination of the nuclear localization of PDIP38 showed that it was nevertheless recruited to
nuclear foci in response to UV. These nuclear foci were identified as spliceosomes (nuclear speckles),
which are associated with transcription and mRNA splicing processes [200]. Treatment with UV
increased the number of cells with visible PDIP38 foci, as well as the number of foci per cell. Thus,
the translocation of PDIP38 to the spliceosomes is a novel DNA damage response [199]. In addition to
genotoxic stress, transcriptional stress induced by α-amanitin also led to translocation of PDIP38 to
the nuclear speckles [199]. Interestingly, the human DNA glycosylase hOGG1 is also translocated to
the nuclear speckles under the influence of UVA [201].
The translocation of PDIP38 in response to UV-damage raises the question of its functions
in the spliceosomes/nuclear speckles, which are associated with transcription and mRNA splicing.
There are a number of genes whose alternative splicing is altered under genotoxic stress [202,203].
One of the more extensively studied of these genes is mouse double minute 2 (MDM2) [202,204].
Mdm2 is an E3 ubiquitin ligase that is a negative regulator of p53 [202,205]. Various genotoxic agents,
e.g., UV, camptothecin, doxorubicin and cisplatin, lead to skipping of as many as eight exons, resulting
in disruption of Mdm2 function and of p53 regulation [205]. Alternative spliced variants of Mdm2 also
can exhibit growth regulatory properties independent of p53 and induce tumorigenesis [206–209].
Analysis of the UV induced Mdm2 splice variants in A549 cells showed that this was dependent
on PDIP38, as their levels were suppressed in PDIP38 depleted cells [199]. While the extent
and mechanisms that underlie the basis for the requirement for PDIP38 in Mdm2 alternative
splicing are unknown, it may be another example of the interplay or crosstalk between DNA
damage/repair processes and RNA transcription/splicing in the maintenance of genomic stability and
cell survival [203,210,211]. This crosstalk has largely focused on RNA binding proteins, but also on
the involvement of DNA damage response proteins in regulating splicing factors [210]. The effects of
PDIP38 in modulating the splicing of Mdm2, a key regulator of p53, falls into this category, and may
represent one of its important functions.
4.4. PDIP38 Binds to p22phox and Regulates the Activity of the Nox4/p22phox NADPH Oxidase
Nox4 (NADPH oxidase 4) is one of seven transmembrane NADPH oxidases that generate
reactive oxygen species (ROS): superoxide and H2 O2 [212–215]. The generation of ROS by
the NOX enzymes occurs physiologically in response to various stimuli; these ROS act on signal
transduction pathways [212,213,216,217]. Nox4 is widely distributed in tissues, with the highest
levels in kidney [213]. Biochemical analysis of partially purified membrane free preparations of Nox4
revealed that Nox4 has a high Km for O2 , and functions as an oxygen sensor, in that its activity responds
to the physiological pO2 [218]. These studies also demonstrated that the Nox4 reaction generates H2 O2
as the primary product with a smaller amount of superoxide [218]. This response to pO2 has relevance
to the proposed role for Nox4 as an oxygen sensor that produces H2 O2 as a signaling molecule [218].
Four of the Nox enzymes including Nox4 are associated with p22phox, which acts as a subunit that
interacts with regulatory proteins in response to cellular stimuli [212,219]. However, Nox4 binds
p22phox which is required for its activity, and is regarded as being constitutively active [213,215].
The role of PDIP38 in regulating Nox4 functions has been extensively studied in the cardiovascular
system [215,219]. PDIP38 was found to bind to p22phox and to activate the Nox4/p22phox enzyme
in vascular smooth muscle cells [220]. The latter study supports the view that PDIP38 is involved
in Nox4 localization, focal adhesion integrity, stress fiber formation, and plays a role in the maintenance
of vascular smooth muscle cell cytoskeletal functions. PDIP38 was found to co-localize with p22phox
at focal adhesions and stress fibers [220]. Overexpression of PDIP38 in vascular smooth muscle cells
increased NADPH oxidase activity several fold in a Nox4 dependent manner [220]. PDIP38 also
regulates vascular smooth muscle cell migration by regulating focal adhesion turnover and traction
force generation [221]. PDIP38 knockout in mice has shown that it is essential for development,
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as this led to perinatal lethality [222]. Analysis of aortas from heterozygous mice showed that these
exhibited abnormal structures and decreased contraction and compliance that are consistent with
a role in vascular function and integrity. Mouse embryonic fibroblasts derived from the knockout mice
exhibit defective growth characteristics, alterations in cell cycle progression and expression of cell
cycle proteins [223]. The subcellular localizations of Nox4/p22phox and PDIP38 in vascular smooth
muscle cells also raises questions regarding how these integrate into the fact that the Nox enzymes
are membrane associated proteins [212].
4.5. Summary
PDIP38 is unusual in that there is evidence for its role in a number of cellular functions, emanating
from the discovery of multiple protein partners. In addition to Pol δ and PCNA, PDIP38 interacts with
Pol η and other TLS pols. These findings together indicate a role for PDIP38 in regulating translesion
synthesis, while its association with Pol δ suggests it may be involved in the mechanisms or regulation
of the interchange between the TLS pols and Pol δ. In addition, PDIP38 is likely under regulation
from DNA damage signaling pathways and is translocated to the spliceosomes where it affects Mdm2
splicing and thereby p53 regulation.
Nevertheless, the studies of PDIP38 are still in their early stages, and its multifunctional nature
poses significant technical challenges to the use of gene depletion or knockouts either in cells or animals,
as these approaches may not allow unambiguous cause and effect relationships. Thus, much further
investigation is required to establish how these functions are accomplished at the molecular level,
as well as the cellular advantages of the investiture of these functions in a single protein. These require
biochemical approaches and, in particular, the elucidation of PDIP38 structure and its complexes
with its partners. These could lead to strategies for the use of targeted mutations that could provide
the means for isolating cause and effect in gene depletion experiments.
Acknowledgments: Studies reported from this laboratory were supported by grants from the National Institutes
of Health (GM031793 to Marietta Y. W. T. Lee) and the National Institute of Environmental Health Science
(ES014737 to Marietta Y. W. T. Lee and Zhongtao Zhang).
Author Contributions: All authors contributed to the manuscript and approved the final version.
Conflicts of Interest: The authors declare no conflicts of interest.

References
1.
2.

3.
4.
5.

6.

7.
8.

Kornberg, A. Ten commandments: Lessons from the enzymology of DNA replication. J. Bacteriol. 2000, 182,
3613–3618. [CrossRef] [PubMed]
Barnes, R.; Eckert, K. Maintenance of Genome Integrity: How Mammalian Cells Orchestrate Genome
Duplication by Coordinating Replicative and Specialized DNA Polymerases. Genes 2017, 8, 19. [CrossRef]
[PubMed]
Nicolas, E.; Golemis, E.A.; Arora, S. POLD1: Central mediator of DNA replication and repair, and implication
in cancer and other pathologies. Gene 2016, 590, 128–141. [CrossRef] [PubMed]
Weissbach, A. Eukaryotic DNA polymerases. Annu. Rev. Biochem. 1977, 46, 25–47. [CrossRef] [PubMed]
Brutlag, D.; Kornberg, A. Enzymatic synthesis of deoxyribonucleic acid. 36. A proofreading function for
the 30 leads to 50 exonuclease activity in deoxyribonucleic acid polymerases. J. Biol. Chem. 1972, 247, 241–248.
[PubMed]
Muzyczka, N.; Poland, R.L.; Bessman, M.J. Studies on the biochemical basis of spontaneous mutation. I.
A comparison of the deoxyribonucleic acid polymerases of mutator, antimutator, and wild type strains of
bacteriophage T4. J. Biol. Chem. 1972, 247, 7116–7122. [PubMed]
Reha-Krantz, L.J. DNA polymerase proofreading: Multiple roles maintain genome stability. Biochim. Biophys.
Acta 2010, 1804, 1049–1063. [CrossRef] [PubMed]
Byrnes, J.J.; Downey, K.M.; Black, V.; Esserman, L.; So, A.G. Selective Inhibition of the 30 to 50 Exonuclease
Activity Associated with Mammalian DNA Polymerase δ. In Miami Winter Symposium: Cancer Enzymology;
Schultz, J., Ahmad, F., Eds.; Academic Press: Cambridge, MA, USA, 1976; Volume 12, pp. 245–264.

Genes 2017, 8, 190

9.
10.

11.

12.

13.
14.
15.
16.
17.
18.
19.

20.
21.

22.
23.

24.
25.
26.

27.
28.

29.
30.

20 of 30

Byrnes, J.J.; Downey, K.M.; Black, V.L.; So, A.G. A new mammalian DNA polymerase with 30 to 50 exonuclease
activity: DNA polymerase δ. Biochemistry 1976, 15, 2817–2823. [CrossRef] [PubMed]
Byrnes, J.J.; Downey, K.M.; Que, B.G.; Lee, M.Y.; Black, V.L.; So, A.G. Selective inhibition of the 30 to 50
exonuclease activity associated with DNA polymerases: A mechanism of mutagenesis. Biochemistry 1977, 16,
3740–3746. [CrossRef] [PubMed]
Lee, M.Y.; Byrnes, J.J.; Downey, K.M.; So, A.G. Mechanism of inhibition of deoxyribonucleic acid synthesis by
1-beta-D-arabinofuranosyladenosine triphosphate and its potentiation by 6-mercaptopurine ribonucleoside
50 -monophosphate. Biochemistry 1980, 19, 215–219. [CrossRef] [PubMed]
Lee, M.Y.; Tan, C.K.; So, A.G.; Downey, K.M. Purification of deoxyribonucleic acid polymerase δ from
calf thymus: Partial characterization of physical properties. Biochemistry 1980, 19, 2096–2101. [CrossRef]
[PubMed]
Lee, M.Y.; Tan, C.K.; Downey, K.M.; So, A.G. Structural and functional properties of calf thymus DNA
polymerase δ. Prog. Nucleic Acid Res. Mol. Biol. 1981, 26, 83–96. [PubMed]
Lee, M.Y.; Tan, C.K.; Downey, K.M.; So, A.G. Further studies on calf thymus DNA polymerase δ purified to
homogeneity by a new procedure. Biochemistry 1984, 23, 1906–1913. [CrossRef] [PubMed]
Lee, M.Y.; Toomey, N.L.; Wright, G.E. Differential inhibition of human placental DNA polymerases δ and α
by BuPdGTP and BuAdATP. Nucleic Acids Res. 1985, 13, 8623–8630. [CrossRef] [PubMed]
Lee, M.Y.; Toomey, N.L. Human placental DNA polymerase δ: Identification of a 170-kilodalton polypeptide
by activity staining and immunoblotting. Biochemistry 1987, 26, 1076–1085. [CrossRef] [PubMed]
Lee, M.Y. Isolation of multiple forms of DNA polymerase δ: Evidence of proteolytic modification during
isolation. Biochemistry 1988, 27, 5188–5193. [CrossRef] [PubMed]
Lee, M.Y.; Alejandro, R.; Toomey, N.L. Immunochemical studies of DNA polymerase δ: Relationships with
DNA polymerase α. Arch. Biochem. Biophys. 1989, 272, 1–9. [CrossRef]
Lee, M.Y.; Jiang, Y.Q.; Zhang, S.J.; Toomey, N.L. Characterization of human DNA polymerase δ and its
immunochemical relationships with DNA polymerase α and epsilon. J. Biol. Chem. 1991, 266, 2423–2429.
[PubMed]
Wong, S.W.; Syvaoja, J.; Tan, C.K.; Downey, K.M.; So, A.G.; Linn, S.; Wang, T.S. DNA polymerases α and δ
are immunologically and structurally distinct. J. Biol. Chem. 1989, 264, 5924–5928. [PubMed]
Zhang, J.; Chung, D.W.; Tan, C.K.; Downey, K.M.; Davie, E.W.; So, A.G. Primary structure of the catalytic
subunit of calf thymus DNA polymerase δ: Sequence similarities with other DNA polymerases. Biochemistry
1991, 30, 11742–11750. [CrossRef] [PubMed]
Hao, H.; Jiang, Y.; Zhang, S.J.; Zhang, P.; Zeng, R.X.; Lee, M.Y. Structural and functional relationships of
human DNA polymerases. Chromosoma 1992, 102, S121–S127. [CrossRef] [PubMed]
Yang, C.L.; Chang, L.S.; Zhang, P.; Hao, H.; Zhu, L.; Toomey, N.L.; Lee, M.Y. Molecular cloning of the cDNA
for the catalytic subunit of human DNA polymerase δ. Nucleic Acids Res. 1992, 20, 735–745. [CrossRef]
[PubMed]
Crute, J.J.; Wahl, A.F.; Bambara, R.A. Purification and characterization of two new high molecular weight
forms of DNA polymerase δ. Biochemistry 1986, 25, 26–36. [CrossRef] [PubMed]
Syvaoja, J.; Linn, S. Characterization of a large form of DNA polymerase δ from HeLa cells that is insensitive
to proliferating cell nuclear antigen. J. Biol. Chem. 1989, 264, 2489–2497. [PubMed]
Burgers, P.M.; Bambara, R.A.; Campbell, J.L.; Chang, L.M.; Downey, K.M.; Hubscher, U.; Lee, M.Y.; Linn, S.M.;
So, A.G.; Spadari, S. Revised nomenclature for eukaryotic DNA polymerases. Eur. J. Biochem. 1990, 191,
617–618. [CrossRef] [PubMed]
Pospiech, H.; Syvaoja, J.E. DNA polymerase epsilon—More than a polymerase. Sci. World J. 2003, 3, 87–104.
[CrossRef] [PubMed]
Prelich, G.; Tan, C.K.; Kostura, M.; Mathews, M.B.; So, A.G.; Downey, K.M.; Stillman, B. Functional identity
of proliferating cell nuclear antigen and a DNA polymerase-δ auxiliary protein. Nature 1987, 326, 517–520.
[CrossRef] [PubMed]
Choe, K.N.; Moldovan, G.L. Forging Ahead through Darkness: PCNA, Still the Principal Conductor at
the Replication Fork. Mol. Cell 2017, 65, 380–392. [CrossRef] [PubMed]
Mo, J.; Liu, L.; Leon, A.; Mazloum, N.; Lee, M.Y. Evidence that DNA polymerase δ isolated by immunoaffinity
chromatography exhibits high-molecular weight characteristics and is associated with the KIAA0039 protein
and RPA. Biochemistry 2000, 39, 7245–7254. [CrossRef] [PubMed]

Genes 2017, 8, 190

31.

32.
33.
34.
35.

36.

37.

38.
39.

40.
41.

42.

43.

44.

45.
46.

47.

48.

49.

50.

21 of 30

Hughes, P.; Tratner, I.; Ducoux, M.; Piard, K.; Baldacci, G. Isolation and identification of the third subunit
of mammalian DNA polymerase δ by PCNA-affinity chromatography of mouse FM3A cell extracts.
Nucleic Acids Res. 1999, 27, 2108–2114. [CrossRef] [PubMed]
Liu, L.; Mo, J.; Rodriguez-Belmonte, E.M.; Lee, M.Y. Identification of a fourth subunit of mammalian DNA
polymerase δ. J. Biol. Chem. 2000, 275, 18739–18744. [CrossRef] [PubMed]
Garg, P.; Burgers, P.M. DNA polymerases that propagate the eukaryotic DNA replication fork. Crit. Rev.
Biochem. Mol. Biol. 2005, 40, 115–128. [CrossRef] [PubMed]
Gerik, K.J.; Li, X.; Pautz, A.; Burgers, P.M. Characterization of the two small subunits of Saccharomyces
cerevisiae DNA polymerase δ. J. Biol. Chem. 1998, 273, 19747–19755. [CrossRef] [PubMed]
Reynolds, N.; Watt, A.; Fantes, P.A.; MacNeill, S.A. Cdm1, the smallest subunit of DNA polymerase d
in the fission yeast Schizosaccharomyces pombe, is non-essential for growth and division. Curr. Genet. 1998,
34, 250–258. [CrossRef] [PubMed]
Zuo, S.; Gibbs, E.; Kelman, Z.; Wang, T.S.; O’Donnell, M.; MacNeill, S.A.; Hurwitz, J. DNA polymerase
δ isolated from Schizosaccharomyces pombe contains five subunits. Proc. Natl. Acad. Sci. USA 1997, 94,
11244–11249. [CrossRef]
Zuo, S.; Bermudez, V.; Zhang, G.; Kelman, Z.; Hurwitz, J. Structure and activity associated with multiple
forms of Schizosaccharomyces pombe DNA polymerase δ. J. Biol. Chem. 2000, 275, 5153–5162. [CrossRef]
[PubMed]
MacNeill, S.A.; Moreno, S.; Reynolds, N.; Nurse, P.; Fantes, P.A. The fission yeast Cdc1 protein, a homologue
of the small subunit of DNA polymerase δ, binds to Pol3 and Cdc27. EMBO J. 1996, 15, 4613–4628. [PubMed]
Bermudez, V.P.; MacNeill, S.A.; Tappin, I.; Hurwitz, J. The influence of the Cdc27 subunit on the properties
of the Schizosaccharomyces pombe DNA polymerase δ. J. Biol. Chem. 2002, 277, 36853–36862. [CrossRef]
[PubMed]
Johansson, E.; Majka, J.; Burgers, P.M. Structure of DNA polymerase δ from Saccharomyces cerevisiae.
J. Biol. Chem. 2001, 276, 43824–43828. [CrossRef] [PubMed]
Zhang, P.; Mo, J.Y.; Perez, A.; Leon, A.; Liu, L.; Mazloum, N.; Xu, H.; Lee, M.Y. Direct interaction of
proliferating cell nuclear antigen with the p125 catalytic subunit of mammalian DNA polymerase δ.
J. Biol. Chem. 1999, 274, 26647–26653. [CrossRef] [PubMed]
Zhang, P.; Sun, Y.; Hsu, H.; Zhang, L.; Zhang, Y.; Lee, M.Y. The interdomain connector loop of human PCNA
is involved in a direct interaction with human polymerase δ. J. Biol. Chem. 1998, 273, 713–719. [CrossRef]
[PubMed]
Roos, G.; Jiang, Y.; Landberg, G.; Nielsen, N.H.; Zhang, P.; Lee, M.Y. Determination of the epitope of
an inhibitory antibody to proliferating cell nuclear antigen. Exp. Cell Res. 1996, 226, 208–213. [CrossRef]
[PubMed]
Zhang, S.J.; Zeng, X.R.; Zhang, P.; Toomey, N.L.; Chuang, R.Y.; Chang, L.S.; Lee, M.Y. A conserved region
in the amino terminus of DNA polymerase δ is involved in proliferating cell nuclear antigen binding.
J. Biol. Chem. 1995, 270, 7988–7992. [CrossRef] [PubMed]
Li, H.; Xie, B.; Zhou, Y.; Rahmeh, A.; Trusa, S.; Zhang, S.; Gao, Y.; Lee, E.Y.; Lee, M.Y. Functional roles of p12,
the fourth subunit of human DNA polymerase δ. J. Biol. Chem. 2006, 281, 14748–14755. [CrossRef] [PubMed]
Lu, X.; Tan, C.K.; Zhou, J.Q.; You, M.; Carastro, L.M.; Downey, K.M.; So, A.G. Direct interaction of
proliferating cell nuclear antigen with the small subunit of DNA polymerase δ. J. Biol. Chem. 2002, 277,
24340–24345. [CrossRef] [PubMed]
Wang, Y.; Zhang, Q.; Chen, H.; Li, X.; Mai, W.; Chen, K.; Zhang, S.; Lee, E.Y.; Lee, M.Y.; Zhou, Y. p50, the Small
Subunit of DNA Polymerase ∆, Is Required for Mediation of the Interaction of Polymerase ∆ Subassemblies
with PCNA. PLoS ONE 2011, 6, e27092. [CrossRef] [PubMed]
Rahmeh, A.A.; Zhou, Y.; Xie, B.; Li, H.; Lee, E.Y.; Lee, M.Y. Phosphorylation of the p68 Subunit of Pol ∆ Acts
as a Molecular Switch to Regulate Its Interaction with PCNA. Biochemistry 2012, 51, 416–424. [CrossRef]
[PubMed]
Podust, V.N.; Chang, L.S.; Ott, R.; Dianov, G.L.; Fanning, E. Reconstitution of human DNA polymerase δ
using recombinant baculoviruses: The p12 subunit potentiates DNA polymerizing activity of the four-subunit
enzyme. J. Biol. Chem. 2002, 277, 3894–3901. [CrossRef] [PubMed]
Xie, B.; Mazloum, N.; Liu, L.; Rahmeh, A.; Li, H.; Lee, M.Y. Reconstitution and characterization of the human
DNA polymerase δ four-subunit holoenzyme. Biochemistry 2002, 41, 13133–13142. [CrossRef] [PubMed]

Genes 2017, 8, 190

51.

52.
53.
54.
55.
56.

57.

58.

59.

60.

61.

62.
63.
64.
65.

66.
67.
68.

69.
70.
71.
72.

22 of 30

Zhou, Y.; Meng, X.; Zhang, S.; Lee, E.Y.; Lee, M.Y. Characterization of human DNA polymerase δ and its
subassemblies reconstituted by expression in the multibac system. PLoS ONE 2012, 7, e39156. [CrossRef]
[PubMed]
Masuda, Y.; Suzuki, M.; Piao, J.; Gu, Y.; Tsurimoto, T.; Kamiya, K. Dynamics of human replication factors
in the elongation phase of DNA replication. Nucleic Acids Res. 2007, 35, 6904–6916. [CrossRef] [PubMed]
Jiang, Y.; Zhang, S.J.; Wu, S.M.; Lee, M.Y. Immunoaffinity purification of DNA polymerase δ. Arch. Biochem.
Biophys. 1995, 320, 297–304. [CrossRef]
Podust, V.N.; Georgaki, A.; Strack, B.; Hubscher, U. Calf thymus RF-C as an essential component for DNA
polymerase δ and epsilon holoenzymes function. Nucleic Acids Res. 1992, 20, 4159–4165. [CrossRef] [PubMed]
Burgers, P.M.; Gerik, K.J. Structure and processivity of two forms of Saccharomyces cerevisiae DNA polymerase
δ. J. Biol. Chem. 1998, 273, 19756–19762. [CrossRef] [PubMed]
Wang, X.; Zhang, S.; Zheng, R.; Yue, F.; Lin, S.H.; Rahmeh, A.A.; Lee, E.Y.; Zhang, Z.; Lee, M.Y. PDIP46 (DNA
polymerase δ interacting protein 46) is an activating factor for human DNA polymerase δ. Oncotarget 2016, 7,
6294–6313. [CrossRef] [PubMed]
Gao, Y.; Zhou, Y.; Xie, B.; Zhang, S.; Rahmeh, A.; Huang, H.S.; Lee, M.Y.; Lee, E.Y. Protein phosphatase-1
is targeted to DNA polymerase δ via an interaction with the p68 subunit. Biochemistry 2008, 47, 11367–11376.
[CrossRef] [PubMed]
Lee, M.Y.; Zhang, S.; Lin, S.H.; Chea, J.; Wang, X.; LeRoy, C.; Wong, A.; Zhang, Z.; Lee, E.Y. Regulation of
human DNA polymerase ∆ in the cellular responses to DNA damage. Environ. Mol. Mutagen. 2012, 53,
683–698. [CrossRef] [PubMed]
Lee, M.Y.; Zhang, S.; Lin, S.H.; Wang, X.; Darzynkiewicz, Z.; Zhang, Z.; Lee, E.Y. The tail that wags the dog:
p12, the smallest subunit of DNA polymerase δ, is degraded by ubiquitin ligases in response to DNA damage
and during cell cycle progression. Cell Cycle 2014, 13, 23–31. [CrossRef] [PubMed]
Zhang, S.; Zhou, Y.; Trusa, S.; Meng, X.; Lee, E.Y.; Lee, M.Y. A novel DNA damage response: Rapid
degradation of the p12 subunit of DNA polymerase δ. J. Biol. Chem. 2007, 282, 15330–15340. [CrossRef]
[PubMed]
Zhang, S.; Zhao, H.; Darzynkiewicz, Z.; Zhou, P.; Zhang, Z.; Lee, E.Y.; Lee, M.Y. A novel function of
CRL4Cdt2: Regulation of the subunit structure of DNA polymerase δ in response to DNA damage and
during the S phase. J. Biol. Chem. 2013, 288, 29950–29961. [CrossRef] [PubMed]
Kaufmann, W.K. The human intra-S checkpoint response to UVC-induced DNA damage. Carcinogenesis
2010, 31, 751–765. [CrossRef] [PubMed]
Cimprich, K.A.; Cortez, D. ATR: An essential regulator of genome integrity. Nat. Rev. Mol. Cell Biol. 2008, 9,
616–627. [CrossRef] [PubMed]
Flynn, R.L.; Zou, L. ATR: A master conductor of cellular responses to DNA replication stress. Trends Biochem.
Sci. 2011, 36, 133–140. [CrossRef] [PubMed]
Conti, C.; Seiler, J.A.; Pommier, Y. The mammalian DNA replication elongation checkpoint: Implication of
Chk1 and relationship with origin firing as determined by single DNA molecule and single cell analyses.
Cell Cycle 2007, 6, 2760–2767. [CrossRef] [PubMed]
Warren, J.J.; Forsberg, L.J.; Beese, L.S. The structural basis for the mutagenicity of O(6)-methyl-guanine
lesions. Proc. Natl. Acad. Sci. USA 2006, 103, 19701–19706. [CrossRef] [PubMed]
Hsu, G.W.; Ober, M.; Carell, T.; Beese, L.S. Error-prone replication of oxidatively damaged DNA by
a high-fidelity DNA polymerase. Nature 2004, 431, 217–221. [CrossRef] [PubMed]
Meng, X.; Zhou, Y.; Zhang, S.; Lee, E.Y.; Frick, D.N.; Lee, M.Y. DNA damage alters DNA polymerase δ to
a form that exhibits increased discrimination against modified template bases and mismatched primers.
Nucleic Acids Res. 2009, 37, 647–657. [CrossRef] [PubMed]
Johnson, K.A. Conformational coupling in DNA polymerase fidelity. Annu. Rev. Biochem. 1993, 62, 685–713.
[CrossRef] [PubMed]
Kunkel, T.A.; Bebenek, K. DNA replication fidelity. Annu. Rev. Biochem. 2000, 69, 497–529. [CrossRef]
[PubMed]
Steitz, T.A. DNA polymerases: Structural diversity and common mechanisms. J. Biol. Chem. 1999, 274,
17395–17398. [CrossRef] [PubMed]
Shamoo, Y.; Steitz, T.A. Building a replisome from interacting pieces: Sliding clamp complexed to a peptide
from DNA polymerase and a polymerase editing complex. Cell 1999, 99, 155–166. [CrossRef]

Genes 2017, 8, 190

73.
74.
75.
76.

77.
78.
79.

80.

81.
82.
83.
84.
85.
86.
87.
88.
89.
90.
91.

92.
93.

94.

95.

23 of 30

Donlin, M.J.; Patel, S.S.; Johnson, K.A. Kinetic partitioning between the exonuclease and polymerase sites
in DNA error correction. Biochemistry 1991, 30, 538–546. [CrossRef] [PubMed]
Khare, V.; Eckert, K.A. The proofreading 30 -50 exonuclease activity of DNA polymerases: A kinetic barrier to
translesion DNA synthesis. Mutat. Res. 2002, 510, 45–54. [CrossRef]
Meng, X.; Zhou, Y.; Lee, E.Y.; Lee, M.Y.; Frick, D.N. The p12 subunit of human polymerase δ modulates
the rate and fidelity of DNA synthesis. Biochemistry 2010, 49, 3545–3554. [CrossRef] [PubMed]
Ogi, T.; Limsirichaikul, S.; Overmeer, R.M.; Volker, M.; Takenaka, K.; Cloney, R.; Nakazawa, Y.; Niimi, A.;
Miki, Y.; Jaspers, N.G.; et al. Three DNA polymerases, recruited by different mechanisms, carry out NER
repair synthesis in human cells. Mol. Cell 2010, 37, 714–727. [CrossRef] [PubMed]
Terai, K.; Shibata, E.; Abbas, T.; Dutta, A. Degradation of p12 Subunit by CRL4Cdt2 E3 Ligase Inhibits Fork
Progression after DNA Damage. J. Biol. Chem. 2013, 288, 30509–30514. [CrossRef] [PubMed]
Bekker-Jensen, S.; Mailand, N. Assembly and function of DNA double-strand break repair foci in mammalian
cells. DNA Repair 2010, 9, 1219–1228. [CrossRef] [PubMed]
Mailand, N.; Bekker-Jensen, S.; Faustrup, H.; Melander, F.; Bartek, J.; Lukas, C.; Lukas, J. RNF8 ubiquitylates
histones at DNA double-strand breaks and promotes assembly of repair proteins. Cell 2007, 131, 887–900.
[CrossRef] [PubMed]
Huen, M.S.; Grant, R.; Manke, I.; Minn, K.; Yu, X.; Yaffe, M.B.; Chen, J. RNF8 transduces the DNA-damage
signal via histone ubiquitylation and checkpoint protein assembly. Cell 2007, 131, 901–914. [CrossRef]
[PubMed]
Harper, J.W.; Elledge, S.J. The DNA damage response: Ten years after. Mol. Cell 2007, 28, 739–745. [CrossRef]
[PubMed]
Yan, J.; Jetten, A.M. RAP80 and RNF8, key players in the recruitment of repair proteins to DNA damage
sites. Cancer Lett. 2008, 271, 179–190. [CrossRef] [PubMed]
Sirbu, B.M.; Cortez, D. DNA damage response: Three levels of DNA repair regulation. Cold Spring Harb.
Perspect. Biol. 2013, 5, a012724. [CrossRef] [PubMed]
Chea, J.; Zhang, S.; Zhao, H.; Zhang, Z.; Lee, E.Y.; Darzynkiewicz, Z.; Lee, M.Y. Spatiotemporal recruitment
of human DNA polymerase δ to sites of UV damage. Cell Cycle 2012, 11, 2885–2895. [CrossRef] [PubMed]
Andersen, P.L.; Xu, F.; Xiao, W. Eukaryotic DNA damage tolerance and translesion synthesis through
covalent modifications of PCNA. Cell Res. 2008, 18, 162–173. [CrossRef] [PubMed]
Chen, J.; Bozza, W.; Zhuang, Z. Ubiquitination of PCNA and its essential role in eukaryotic translesion
synthesis. Cell Biochem. Biophys. 2011, 60, 47–60. [CrossRef] [PubMed]
Ghosal, G.; Chen, J. DNA damage tolerance: A double-edged sword guarding the genome. Transl. Cancer
Res. 2013, 2, 107–129. [PubMed]
Sale, J.E.; Lehmann, A.R.; Woodgate, R. Y-family DNA polymerases and their role in tolerance of cellular
DNA damage. Nat. Rev. Mol. Cell Biol. 2012, 13, 141–152. [CrossRef] [PubMed]
Vaisman, A.; Woodgate, R. Translesion DNA polymerases in eukaryotes: What makes them tick? Crit. Rev.
Biochem. Mol. Biol. 2017, 1–30. [CrossRef] [PubMed]
Hoege, C.; Pfander, B.; Moldovan, G.L.; Pyrowolakis, G.; Jentsch, S. RAD6-dependent DNA repair is linked
to modification of PCNA by ubiquitin and SUMO. Nature 2002, 419, 135–141. [CrossRef] [PubMed]
Kannouche, P.L.; Wing, J.; Lehmann, A.R. Interaction of human DNA polymerase eta with monoubiquitinated
PCNA: A possible mechanism for the polymerase switch in response to DNA damage. Mol. Cell 2004, 14,
491–500. [CrossRef]
Kannouche, P.L.; Lehmann, A.R. Ubiquitination of PCNA and the polymerase switch in human cells.
Cell Cycle 2004, 3, 1011–1013. [CrossRef] [PubMed]
Zhang, Z.; Zhang, S.; Lin, S.H.; Wang, X.; Wu, L.; Lee, E.Y.; Lee, M.Y. Structure of monoubiquitinated
PCNA: Implications for DNA polymerase switching and Okazaki fragment maturation. Cell Cycle 2012, 11,
2128–2136. [CrossRef] [PubMed]
Murga, M.; Lecona, E.; Kamileri, I.; Diaz, M.; Lugli, N.; Sotiriou, S.K.; Anton, M.E.; Mendez, J.;
Halazonetis, T.D.; Fernandez-Capetillo, O. POLD3 Is Haploinsufficient for DNA Replication in Mice. Mol. Cell
2016, 63, 877–883. [CrossRef] [PubMed]
Hirota, K.; Yoshikiyo, K.; Guilbaud, G.; Tsurimoto, T.; Murai, J.; Tsuda, M.; Phillips, L.G.; Narita, T.;
Nishihara, K.; Kobayashi, K.; et al. The POLD3 subunit of DNA polymerase δ can promote translesion
synthesis independently of DNA polymerase ζ. Nucleic Acids Res. 2015, 43, 1671–1683. [CrossRef] [PubMed]

Genes 2017, 8, 190

96.
97.

98.

99.
100.

101.

102.
103.
104.
105.

106.
107.
108.

109.

110.
111.

112.

113.

114.
115.
116.

24 of 30

Johnson, R.E.; Prakash, L.; Prakash, S. Pol31 and Pol32 subunits of yeast DNA polymerase δ are also essential
subunits of DNA polymerase ζ. Proc. Natl. Acad. Sci. USA 2012, 109, 12455–12460. [CrossRef] [PubMed]
Baranovskiy, A.G.; Lada, A.G.; Siebler, H.; Zhang, Y.; Pavlov, Y.I.; Tahirov, T.H. DNA polymerases δ and ζ
switching by sharing the accessory subunits of DNA polymerase δ. J. Biol. Chem. 2012, 287, 17281–17287.
[CrossRef] [PubMed]
Zhang, S.; Zhou, Y.; Sarkeshik, A.; Yates, J.R.; Thomson, T.; Zhang, Z.; Lee, E.Y.; Lee, M.Y. Identification of
RNF8 as a Ubiquitin Ligase Involved in Targeting the p12 Subunit of DNA Polymerase δ for Degradation
in Response to DNA Damage. J. Biol. Chem. 2013, 288, 2941–2950. [CrossRef] [PubMed]
Brzovic, P.S.; Klevit, R.E. Ubiquitin transfer from the E2 perspective: Why is UbcH5 so promiscuous?
Cell Cycle 2006, 5, 2867–2873. [CrossRef] [PubMed]
Wang, B.;
Elledge, S.J. Ubc13/Rnf8 ubiquitin ligases control foci formation of the
Rap80/Abraxas/Brca1/Brcc36 complex in response to DNA damage. Proc. Natl. Acad. Sci. USA
2007, 104, 20759–20763. [CrossRef] [PubMed]
Marteijn, J.A.; Bekker-Jensen, S.; Mailand, N.; Lans, H.; Schwertman, P.; Gourdin, A.M.; Dantuma, N.P.;
Lukas, J.; Vermeulen, W. Nucleotide excision repair-induced H2A ubiquitination is dependent on MDC1 and
RNF8 and reveals a universal DNA damage response. J. Cell Biol. 2009, 186, 835–847. [CrossRef] [PubMed]
Zhang, S.; Chea, J.; Meng, X.; Zhou, Y.; Lee, E.Y.; Lee, M.Y. PCNA is ubiquitinated by RNF8. Cell Cycle 2008,
7, 3399–3404. [CrossRef] [PubMed]
Abbas, T.; Dutta, A. CRL4Cdt2: Master coordinator of cell cycle progression and genome stability. Cell Cycle
2011, 10, 241–249. [CrossRef] [PubMed]
Hannah, J.; Zhou, P. Distinct and overlapping functions of the cullin E3 ligase scaffolding proteins CUL4A
and CUL4B. Gene 2015, 573, 33–45. [CrossRef] [PubMed]
Havens, C.G.; Shobnam, N.; Guarino, E.; Centore, R.C.; Zou, L.; Kearsey, S.E.; Walter, J.C. Direct Role for
proliferating cell nuclear antigen (PCNA) in substrate recognition by the E3 Ubiquitin ligase CRL4-Cdt2.
J. Biol. Chem. 2012, 287, 11410–11421. [CrossRef] [PubMed]
Havens, C.G.; Walter, J.C. Mechanism of CRL4(Cdt2), a PCNA-dependent E3 ubiquitin ligase. Genes Dev.
2011, 25, 1568–1582. [CrossRef] [PubMed]
Arias, E.E.; Walter, J.C. Replication-dependent destruction of Cdt1 limits DNA replication to a single round
per cell cycle in Xenopus egg extracts. Genes Dev. 2005, 19, 114–126. [CrossRef] [PubMed]
Nishitani, H.; Sugimoto, N.; Roukos, V.; Nakanishi, Y.; Saijo, M.; Obuse, C.; Tsurimoto, T.; Nakayama, K.I.;
Nakayama, K.; Fujita, M.; et al. Two E3 ubiquitin ligases, SCF-Skp2 and DDB1-Cul4, target human Cdt1 for
proteolysis. EMBO J. 2006, 25, 1126–1136. [CrossRef] [PubMed]
Higa, L.A.; Banks, D.; Wu, M.; Kobayashi, R.; Sun, H.; Zhang, H. L2DTL/CDT2 interacts with the
CUL4/DDB1 complex and PCNA and regulates CDT1 proteolysis in response to DNA damage. Cell Cycle
2006, 5, 1675–1680. [CrossRef] [PubMed]
Soria, G.; Gottifredi, V. PCNA-coupled p21 degradation after DNA damage: The exception that confirms
the rule? DNA Repair 2010, 9, 358–364. [CrossRef] [PubMed]
Bendjennat, M.; Boulaire, J.; Jascur, T.; Brickner, H.; Barbier, V.; Sarasin, A.; Fotedar, A.; Fotedar, R. UV
irradiation triggers ubiquitin-dependent degradation of p21(WAF1) to promote DNA repair. Cell 2003, 114,
599–610. [CrossRef] [PubMed]
Higa, L.A.; Mihaylov, I.S.; Banks, D.P.; Zheng, J.; Zhang, H. Radiation-mediated proteolysis of CDT1 by
CUL4-ROC1 and CSN complexes constitutes a new checkpoint. Nat. Cell Biol. 2003, 5, 1008–1015. [CrossRef]
[PubMed]
Abbas, T.; Sivaprasad, U.; Terai, K.; Amador, V.; Pagano, M.; Dutta, A. PCNA-dependent regulation of p21
ubiquitylation and degradation via the CRL4Cdt2 ubiquitin ligase complex. Genes Dev. 2008, 22, 2496–2506.
[CrossRef] [PubMed]
Hu, J.; McCall, C.M.; Ohta, T.; Xiong, Y. Targeted ubiquitination of CDT1 by the DDB1-CUL4A-ROC1 ligase
in response to DNA damage. Nat. Cell Biol. 2004, 6, 1003–1009. [CrossRef] [PubMed]
Hannah, J.; Zhou, P. Regulation of DNA damage response pathways by the cullin-RING ubiquitin ligases.
DNA Repair 2009, 8, 536–543. [CrossRef] [PubMed]
Lin, J.J.; Milhollen, M.A.; Smith, P.G.; Narayanan, U.; Dutta, A. NEDD8-targeting drug MLN4924 elicits DNA
rereplication by stabilizing Cdt1 in S phase, triggering checkpoint activation, apoptosis, and senescence
in cancer cells. Cancer Res. 2010, 70, 10310–10320. [CrossRef] [PubMed]

Genes 2017, 8, 190

25 of 30

117. Seiler, J.A.; Conti, C.; Syed, A.; Aladjem, M.I.; Pommier, Y. The intra-S-phase checkpoint affects both DNA
replication initiation and elongation: Single-cell and -DNA fiber analyses. Mol. Cell Biol. 2007, 27, 5806–5818.
[CrossRef] [PubMed]
118. Zhao, H.; Zhang, S.; Xu, D.; Lee, M.Y.; Zhang, Z.; Lee, E.Y.; Darzynkiewicz, Z. Expression of the p12 subunit
of human DNA polymerase δ (Pol δ), CDK inhibitor p21(WAF1), Cdt1, cyclin A, PCNA and Ki-67 in relation
to DNA replication in individual cells. Cell Cycle 2014, 13, 3529–3540. [CrossRef] [PubMed]
119. Darzynkiewicz, Z.; Zhao, H.; Zhang, S.; Lee, M.Y.; Lee, E.Y.; Zhang, Z. Initiation and termination of DNA
replication during S phase in relation to cyclins D1, E and A, p21WAF1, Cdt1 and the p12 subunit of
DNA polymerase δ revealed in individual cells by cytometry. Oncotarget 2015, 6, 11735–11750. [CrossRef]
[PubMed]
120. Balakrishnan, L.; Bambara, R.A. Okazaki fragment metabolism. Cold Spring Harb. Perspect. Biol. 2013, 5,
a10173. [CrossRef] [PubMed]
121. Garg, P.; Stith, C.M.; Sabouri, N.; Johansson, E.; Burgers, P.M. Idling by DNA polymerase δ maintains
a ligatable nick during lagging-strand DNA replication. Genes Dev. 2004, 18, 2764–2773. [CrossRef] [PubMed]
122. Balakrishnan, L.; Bambara, R.A. FLAP Endonuclease 1. Ann. Rev. Biochem. 2013, 82, 119–138. [CrossRef]
[PubMed]
123. Jin, Y.H.; Ayyagari, R.; Resnick, M.A.; Gordenin, D.A.; Burgers, P.M. Okazaki fragment maturation in yeast.
II. Cooperation between the polymerase and 30 -50 -exonuclease activities of Pol δ in the creation of a ligatable
nick. J. Biol. Chem. 2003, 278, 1626–1633. [CrossRef] [PubMed]
124. Burgers, P.M. It’s all about flaps: DNA2 and checkpoint activation. Cell Cycle 2011, 10, 2417–2418. [CrossRef]
[PubMed]
125. Howes, T.R.; Tomkinson, A.E. DNA ligase I, the replicative DNA ligase. Subcell. Biochem. 2012, 62, 327–341.
[PubMed]
126. Kelly, R.B.; Cozzarelli, N.R.; Deutscher, M.P.; Lehman, I.R.; Kornberg, A. Enzymatic synthesis of
deoxyribonucleic acid. XXXII. Replication of duplex deoxyribonucleic acid by polymerase at a single
strand break. J. Biol. Chem. 1970, 245, 39–45. [PubMed]
127. Lin, S.H.; Wang, X.; Zhang, S.; Zhang, Z.; Lee, E.Y.; Lee, M.Y. Dynamics of Enzymatic Interactions during
Short Flap Human Okazaki Fragment Processing by Two Forms of Human DNA Polymerase δ. DNA Repair
2013, 12, 922–935. [CrossRef] [PubMed]
128. Beattie, T.R.; Bell, S.D. Coordination of multiple enzyme activities by a single PCNA in archaeal Okazaki
fragment maturation. EMBO J. 2012, 31, 1556–1567. [CrossRef] [PubMed]
129. Patel, S.S.; Wong, I.; Johnson, K.A. Pre-steady-state kinetic analysis of processive DNA replication including
complete characterization of an exonuclease-deficient mutant. Biochemistry 1991, 30, 511–525. [CrossRef]
[PubMed]
130. Langston, L.D.; O’Donnell, M. DNA polymerase δ is highly processive with proliferating cell nuclear antigen
and undergoes collision release upon completing DNA. J. Biol. Chem. 2008, 283, 29522–29531. [CrossRef]
[PubMed]
131. Burgers, P.M.; Kunkel, T.A. Eukaryotic DNA Replication Fork. Annu. Rev. Biochem. 2017, 86, 417–438.
[CrossRef] [PubMed]
132. Huang, Q.M.; Akashi, T.; Masuda, Y.; Kamiya, K.; Takahashi, T.; Suzuki, M. Roles of POLD4, smallest subunit
of DNA polymerase δ, in nuclear structures and genomic stability of human cells. Biochem. Biophys. Res.
Commun. 2010, 391, 542–546. [CrossRef] [PubMed]
133. Huang, Q.; Suzuki, M.; Zeng, Y.; Zhang, H.; Yang, D.; Lin, H. Downregulation of POLD4 in Calu6 cells
results in G1-S blockage through suppression of the Akt-Skp2-p27 pathway. Bioorg. Med. Chem. Lett. 2014,
24, 1780–1783. [CrossRef] [PubMed]
134. Liu, L.; Rodriguez-Belmonte, E.M.; Mazloum, N.; Xie, B.; Lee, M.Y. Identification of a novel protein, PDIP38,
that interacts with the p50 subunit of DNA polymerase δ and proliferating cell nuclear antigen. J. Biol. Chem.
2003, 278, 10041–10047. [CrossRef] [PubMed]
135. He, H.; Tan, C.K.; Downey, K.M.; So, A.G. A tumor necrosis factor α- and interleukin 6-inducible protein
that interacts with the small subunit of DNA polymerase δ and proliferating cell nuclear antigen. Proc. Natl.
Acad. Sci. USA 2001, 98, 11979–11984. [CrossRef] [PubMed]
136. Richardson, C.J.; Broenstrup, M.; Fingar, D.C.; Julich, K.; Ballif, B.A.; Gygi, S.; Blenis, J. SKAR is a specific
target of S6 kinase 1 in cell growth control. Curr. Biol. 2004, 14, 1540–1549. [CrossRef] [PubMed]

Genes 2017, 8, 190

26 of 30

137. Magnuson, B.; Ekim, B.; Fingar, D.C. Regulation and function of ribosomal protein S6 kinase (S6K) within
mTOR signalling networks. Biochem. J. 2012, 441, 1–21. [CrossRef] [PubMed]
138. Richardson, C.J.; Schalm, S.S.; Blenis, J. PI3-kinase and TOR: PIKTORing cell growth. Semin. Cell Dev. Biol.
2004, 15, 147–159. [CrossRef] [PubMed]
139. Banko, M.I.; Krzyzanowski, M.K.; Turcza, P.; Maniecka, Z.; Kulis, M.; Kozlowski, P. Identification of amino
acid residues of ERH required for its recruitment to nuclear speckles and replication foci in HeLa cells.
PLoS ONE 2013, 8, e74885. [CrossRef] [PubMed]
140. Ma, X.M.; Yoon, S.O.; Richardson, C.J.; Julich, K.; Blenis, J. SKAR links pre-mRNA splicing to
mTOR/S6K1-mediated enhanced translation efficiency of spliced mRNAs. Cell 2008, 133, 303–313. [CrossRef]
[PubMed]
141. Ma, X.M.; Blenis, J. Molecular mechanisms of mTOR-mediated translational control. Nat. Rev. Mol. Cell Biol.
2009, 10, 307–318. [CrossRef] [PubMed]
142. Fingar, D.C.; Salama, S.; Tsou, C.; Harlow, E.; Blenis, J. Mammalian cell size is controlled by mTOR and its
downstream targets S6K1 and 4EBP1/eIF4E. Genes Dev. 2002, 16, 1472–1487. [CrossRef] [PubMed]
143. Smyk, A.; Szuminska, M.; Uniewicz, K.A.; Graves, L.M.; Kozlowski, P. Human enhancer of rudimentary is a
molecular partner of PDIP46/SKAR, a protein interacting with DNA polymerase δ and S6K1 and regulating
cell growth. FEBS J. 2006, 273, 4728–4741. [CrossRef] [PubMed]
144. Weng, M.T.; Luo, J. The enigmatic ERH protein: Its role in cell cycle, RNA splicing and cancer. Protein Cell
2013, 4, 807–812. [CrossRef] [PubMed]
145. Weng, M.T.; Tung, T.H.; Lee, J.H.; Wei, S.C.; Lin, H.L.; Huang, Y.J.; Wong, J.M.; Luo, J.; Sheu, J.C. Enhancer of
rudimentary homolog regulates DNA damage response in hepatocellular carcinoma. Sci. Rep. 2015, 5, 9357.
[CrossRef] [PubMed]
146. Kavanaugh, G.; Zhao, R.; Guo, Y.; Mohni, K.N.; Glick, G.; Lacy, M.E.; Hutson, M.S.; Ascano, M.; Cortez, D.
Enhancer of Rudimentary Homolog affects the replication stress response through regulation of RNA
processing. Mol. Cell Biol. 2015, 35, 2979–2990. [CrossRef] [PubMed]
147. Gilljam, K.M.; Feyzi, E.; Aas, P.A.; Sousa, M.M.; Muller, R.; Vagbo, C.B.; Catterall, T.C.; Liabakk, N.B.;
Slupphaug, G.; Drablos, F.; et al. Identification of a novel, widespread, and functionally important
PCNA-binding motif. J. Cell Biol. 2009, 186, 645–654. [CrossRef] [PubMed]
148. Gilljam, K.M.; Muller, R.; Liabakk, N.B.; Otterlei, M. Nucleotide excision repair is associated with
the replisome and its efficiency depends on a direct interaction between XPA and PCNA. PLoS ONE
2012, 7, e49199. [CrossRef] [PubMed]
149. Bacquin, A.; Pouvelle, C.; Siaud, N.; Perderiset, M.; Salome-Desnoulez, S.; Tellier-Lebegue, C.; Lopez, B.;
Charbonnier, J.B.; Kannouche, P.L. The helicase FBH1 is tightly regulated by PCNA via CRL4(Cdt2)-mediated
proteolysis in human cells. Nucleic Acids Res. 2013, 41, 6501–6513. [CrossRef] [PubMed]
150. Fu, D.; Samson, L.D.; Hubscher, U.; van Loon, B. The interaction between ALKBH2 DNA repair enzyme
and PCNA is direct, mediated by the hydrophobic pocket of PCNA and perturbed in naturally-occurring
ALKBH2 variants. DNA Repair 2015, 35, 13–18. [CrossRef] [PubMed]
151. O’Donnell, M.; Li, H. The Eukaryotic Replisome Goes Under the Microscope. Curr. Biol. 2016, 26, R247–R256.
[CrossRef] [PubMed]
152. Kang, Y.H.; Farina, A.; Bermudez, V.P.; Tappin, I.; Du, F.; Galal, W.C.; Hurwitz, J. Interaction between
human Ctf4 and the Cdc45/Mcm2-7/GINS (CMG) replicative helicase. Proc. Natl. Acad. Sci. USA 2013, 110,
19760–19765. [CrossRef] [PubMed]
153. Villa, F.; Simon, A.C.; Ortiz Bazan, M.A.; Kilkenny, M.L.; Wirthensohn, D.; Wightman, M.; Matak-Vinkovic, D.;
Pellegrini, L.; Labib, K. Ctf4 Is a Hub in the Eukaryotic Replisome that Links Multiple CIP-Box Proteins to
the CMG Helicase. Mol. Cell 2016, 63, 385–396. [CrossRef] [PubMed]
154. Xie, B.; Li, H.; Wang, Q.; Xie, S.; Rahmeh, A.; Dai, W.; Lee, M.Y. Further characterization of human DNA
polymerase δ interacting protein 38. J. Biol. Chem. 2005, 280, 22375–22384. [CrossRef] [PubMed]
155. Pursell, Z.F.; Isoz, I.; Lundstrom, E.B.; Johansson, E.; Kunkel, T.A. Yeast DNA polymerase epsilon participates
in leading-strand DNA replication. Science 2007, 317, 127–130. [CrossRef] [PubMed]
156. Nick McElhinny, S.A.; Gordenin, D.A.; Stith, C.M.; Burgers, P.M.; Kunkel, T.A. Division of labor at
the eukaryotic replication fork. Mol. Cell 2008, 30, 137–144. [CrossRef] [PubMed]

Genes 2017, 8, 190

27 of 30

157. Larrea, A.A.; Lujan, S.A.; Nick McElhinny, S.A.; Mieczkowski, P.A.; Resnick, M.A.; Gordenin, D.A.;
Kunkel, T.A. Genome-wide model for the normal eukaryotic DNA replication fork. Proc. Natl. Acad.
Sci. USA 2010, 107, 17674–17679. [CrossRef] [PubMed]
158. Johnson, R.E.; Klassen, R.; Prakash, L.; Prakash, S. A Major Role of DNA Polymerase δ in Replication of Both
the Leading and Lagging DNA Strands. Mol. Cell 2015, 59, 163–175. [CrossRef] [PubMed]
159. Eckert, K.A.; Hile, S.E. Every microsatellite is different: Intrinsic DNA features dictate mutagenesis of
common microsatellites present in the human genome. Mol. Carcinog. 2009, 48, 379–388. [CrossRef]
[PubMed]
160. Le, H.P.; Masuda, Y.; Tsurimoto, T.; Maki, S.; Katayama, T.; Furukohri, A.; Maki, H. Short CCG repeat in
huntingtin gene is an obstacle for replicative DNA polymerases, potentially hampering progression of
replication fork. Genes Cells 2015, 20, 817–833. [CrossRef] [PubMed]
161. Hile, S.E.; Wang, X.; Lee, M.Y.; Eckert, K.A. Beyond translesion synthesis: Polymerase k fidelity as a potential
determinant of microsatellite stability. Nucleic Acids Res. 2012, 40, 1636–1647. [CrossRef] [PubMed]
162. Baptiste, B.A.; Eckert, K.A. DNA polymerase k microsatellite synthesis: Two distinct mechanisms of
slippage-mediated errors. Environ. Mol. Mutagen. 2012, 53, 787–796. [CrossRef] [PubMed]
163. Rey, L.; Sidorova, J.M.; Puget, N.; Boudsocq, F.; Biard, D.S.; Monnat, R.J.J.; Cazaux, C.; Hoffmann, J.S. Human
DNA polymerase eta is required for common fragile site stability during unperturbed DNA replication.
Mol. Cell Biol. 2009, 29, 3344–3354. [CrossRef] [PubMed]
164. Bergoglio, V.; Boyer, A.S.; Walsh, E.; Naim, V.; Legube, G.; Lee, M.Y.; Rey, L.; Rosselli, F.; Cazaux, C.;
Eckert, K.A.; et al. DNA synthesis by Pol eta promotes fragile site stability by preventing under-replicated
DNA in mitosis. J. Cell Biol. 2013, 201, 395–408. [CrossRef] [PubMed]
165. Garcia-Exposito, L.; Bournique, E.; Bergoglio, V.; Bose, A.; Barroso-Gonzalez, J.; Zhang, S.; Roncaioli, J.L.;
Lee, M.; Wallace, C.T.; Watkins, S.C.; et al. Proteomic Profiling Reveals a Specific Role for Translesion DNA
Polymerase eta in the Alternative Lengthening of Telomeres. Cell Rep. 2016, 17, 1858–1871. [CrossRef]
[PubMed]
166. Bermudez, V.P.; Farina, A.; Raghavan, V.; Tappin, I.; Hurwitz, J. Studies on Human DNA Polymerase epsilon
and GINS Complex and Their Role in DNA Replication. J. Biol. Chem. 2011, 286, 28963–28977. [CrossRef]
[PubMed]
167. Ganai, R.A.; Zhang, X.P.; Heyer, W.D.; Johansson, E. Strand displacement synthesis by yeast DNA polymerase
epsilon. Nucleic Acids Res. 2016, 44, 8229–8240. [CrossRef] [PubMed]
168. Yeeles, J.T.; Janska, A.; Early, A.; Diffley, J.F. How the Eukaryotic Replisome Achieves Rapid and Efficient
DNA Replication. Mol. Cell 2017, 65, 105–116. [CrossRef] [PubMed]
169. Zhou, J.C.; Janska, A.; Goswami, P.; Renault, L.; Abid Ali, F.; Kotecha, A.; Diffley, J.F.X.; Costa, A. CMG-Pol
epsilon dynamics suggests a mechanism for the establishment of leading-strand synthesis in the eukaryotic
replisome. Proc. Natl. Acad. Sci. USA 2017, 114, 4141–4146. [CrossRef] [PubMed]
170. Kurat, C.F.; Yeeles, J.T.; Patel, H.; Early, A.; Diffley, J.F. Chromatin Controls DNA Replication Origin Selection,
Lagging-Strand Synthesis, and Replication Fork Rates. Mol. Cell 2017, 65, 117–130. [CrossRef] [PubMed]
171. Yeeles, J.T.; Deegan, T.D.; Janska, A.; Early, A.; Diffley, J.F. Regulated eukaryotic DNA replication origin
firing with purified proteins. Nature 2015, 519, 431–435. [CrossRef] [PubMed]
172. Schauer, G.D.; O’Donnell, M.E. Quality control mechanisms exclude incorrect polymerases from
the eukaryotic replication fork. Proc. Natl. Acad. Sci. USA 2017, 114, 675–680. [CrossRef] [PubMed]
173. Yurieva, O.; O’Donnell, M. Reconstitution of a eukaryotic replisome reveals the mechanism of asymmetric
distribution of DNA polymerases. Nucleus 2016, 7, 360–368. [CrossRef] [PubMed]
174. Hedglin, M.; Pandey, B.; Benkovic, S.J. Stability of the human polymerase δ holoenzyme and its implications
in lagging strand DNA synthesis. Proc. Natl. Acad. Sci. USA 2016, 113, E1777–E1786. [CrossRef] [PubMed]
175. Beattie, T.R.; Kapadia, N.; Nicolas, E.; Uphoff, S.; Wollman, A.J.; Leake, M.C.; Reyes-Lamothe, R. Frequent
exchange of the DNA polymerase during bacterial chromosome replication. Elife 2017, 6, e21763. [CrossRef]
[PubMed]
176. Li, J.J.; Kelly, T.J. Simian virus 40 DNA replication in vitro. Proc. Natl. Acad. Sci. USA 1984, 81, 6973–6977.
[CrossRef] [PubMed]
177. Waga, S.; Stillman, B. Anatomy of a DNA replication fork revealed by reconstitution of SV40 DNA replication
in vitro. Nature 1994, 369, 207–212. [CrossRef] [PubMed]

Genes 2017, 8, 190

28 of 30

178. Rytkonen, A.K.; Vaara, M.; Nethanel, T.; Kaufmann, G.; Sormunen, R.; Laara, E.; Nasheuer, H.P.; Rahmeh, A.;
Lee, M.Y.; Syvaoja, J.E.; et al. Distinctive activities of DNA polymerases during human DNA replication.
FEBS J. 2006, 273, 2984–3001. [CrossRef] [PubMed]
179. Friedberg, E.C.; Lehmann, A.R.; Fuchs, R.P. Trading places: How do DNA polymerases switch during
translesion DNA synthesis? Mol. Cell 2005, 18, 499–505. [CrossRef] [PubMed]
180. Lehmann, A.R. Translesion synthesis in mammalian cells. Exp. Cell Res. 2006, 312, 2673–2676. [CrossRef]
[PubMed]
181. Guilliam, T.A.; Doherty, A.J. PrimPol-Prime Time to Reprime. Genes 2017, 8, 20. [CrossRef] [PubMed]
182. Khan, F.H.; Pandian, V.; Ramraj, S.; Natarajan, M.; Aravindan, S.; Herman, T.S.; Aravindan, N. Acquired
genetic alterations in tumor cells dictate the development of high-risk neuroblastoma and clinical outcomes.
BMC Cancer 2015, 15, 514. [CrossRef] [PubMed]
183. Human Protein Atlas. Available online: http://www.proteinatlas.org/ENSG00000100227-POLDIP3/cancer
(accessed on 9 April 2017).
184. COSMIC (Catalogue of Somatic Mutations in Cancer). Available online: http://cancer.sanger.ac.uk/cosmic
(accessed on 9 April 2017).
185. Gakh, O.; Cavadini, P.; Isaya, G. Mitochondrial processing peptidases. Biochim. Biophys. Acta 2002, 1592,
63–77. [CrossRef]
186. Cheng, X.; Kanki, T.; Fukuoh, A.; Ohgaki, K.; Takeya, R.; Aoki, Y.; Hamasaki, N.; Kang, D. PDIP38 associates
with proteins constituting the mitochondrial DNA nucleoid. J. Biochem. 2005, 138, 673–678. [CrossRef]
[PubMed]
187. Arakaki, N.; Nishihama, T.; Kohda, A.; Owaki, H.; Kuramoto, Y.; Abe, R.; Kita, T.; Suenaga, M.; Himeda, T.;
Kuwajima, M.; et al. Regulation of mitochondrial morphology and cell survival by Mitogenin I and
mitochondrial single-stranded DNA binding protein. Biochim. Biophys. Acta 2006, 1760, 1364–1372.
[CrossRef] [PubMed]
188. Klaile, E.; Muller, M.M.; Kannicht, C.; Otto, W.; Singer, B.B.; Reutter, W.; Obrink, B.; Lucka, L. The cell
adhesion receptor carcinoembryonic antigen-related cell adhesion molecule 1 regulates nucleocytoplasmic
trafficking of DNA polymerase δ-interacting protein 38. J. Biol. Chem. 2007, 282, 26629–26640. [CrossRef]
[PubMed]
189. Klaile, E.; Kukalev, A.; Obrink, B.; Muller, M.M. PDIP38 is a novel mitotic spindle-associated protein that
affects spindle organization and chromosome segregation. Cell Cycle 2008, 7, 3180–3186. [CrossRef] [PubMed]
190. Tissier, A.; Janel-Bintz, R.; Coulon, S.; Klaile, E.; Kannouche, P.; Fuchs, R.P.; Cordonnier, A.M. Crosstalk
between replicative and translesional DNA polymerases: PDIP38 interacts directly with Poleta. DNA Repair
2010, 9, 922–928. [CrossRef] [PubMed]
191. Maga, G.; Crespan, E.; Markkanen, E.; Imhof, R.; Furrer, A.; Villani, G.; Hubscher, U.; van Loon, B.
DNA polymerase δ-interacting protein 2 is a processivity factor for DNA polymerase lambda during
8-oxo-7,8-dihydroguanine bypass. Proc. Natl. Acad. Sci. USA 2013, 110, 18850–18855. [CrossRef] [PubMed]
192. Bebenek, K.; Pedersen, L.C.; Kunkel, T.A. Structure-Function Studies of DNA Polymerase lambda.
Biochemistry 2014, 53, 2781–2792. [CrossRef] [PubMed]
193. Mentegari, E.; Kissova, M.; Bavagnoli, L.; Maga, G.; Crespan, E. DNA Polymerases lambda and beta:
The Double-Edged Swords of DNA Repair. Genes 2016, 7, 57. [CrossRef] [PubMed]
194. Waters, L.S.; Minesinger, B.K.; Wiltrout, M.E.; D’Souza, S.; Woodruff, R.V.; Walker, G.C. Eukaryotic translesion
polymerases and their roles and regulation in DNA damage tolerance. Microbiol. Mol. Biol. Rev. 2009, 73,
134–154. [CrossRef] [PubMed]
195. Braithwaite, E.K.; Kedar, P.S.; Stumpo, D.J.; Bertocci, B.; Freedman, J.H.; Samson, L.D.; Wilson, S.H. DNA
polymerases beta and lambda mediate overlapping and independent roles in base excision repair in mouse
embryonic fibroblasts. PLoS ONE 2010, 5, e12229. [CrossRef] [PubMed]
196. Braithwaite, E.K.; Kedar, P.S.; Lan, L.; Polosina, Y.Y.; Asagoshi, K.; Poltoratsky, V.P.; Horton, J.K.; Miller, H.;
Teebor, G.W.; Yasui, A.; et al. DNA polymerase lambda protects mouse fibroblasts against oxidative DNA
damage and is recruited to sites of DNA damage/repair. J. Biol. Chem. 2005, 280, 31641–31647. [CrossRef]
[PubMed]
197. Hubscher, U.; Maga, G. DNA replication and repair bypass machines. Curr. Opin. Chem. Biol. 2011, 15,
627–635. [CrossRef] [PubMed]

Genes 2017, 8, 190

29 of 30

198. Guilliam, T.A.; Bailey, L.J.; Brissett, N.C.; Doherty, A.J. PolDIP2 interacts with human PrimPol and enhances
its DNA polymerase activities. Nucleic Acids Res. 2016, 44, 3317–3329. [CrossRef] [PubMed]
199. Wong, A.; Zhang, S.; Mordue, D.; Wu, J.M.; Zhang, Z.; Darzynkiewicz, Z.; Lee, E.Y.; Lee, M.Y. PDIP38
is translocated to the spliceosomes/nuclear speckles in response to UV-induced DNA damage and is required
for UV-induced alternative splicing of MDM2. Cell Cycle 2013, 12, 3184–3193. [CrossRef] [PubMed]
200. Spector, D.L.; Lamond, A.I. Nuclear speckles. Cold Spring Harb. Perspect. Biol. 2011, 3, a000646. [CrossRef]
[PubMed]
201. Campalans, A.; Amouroux, R.; Bravard, A.; Epe, B.; Radicella, J.P. UVA irradiation induces relocalisation of
the DNA repair protein hOGG1 to nuclear speckles. J. Cell Sci. 2007, 120, 23–32. [CrossRef] [PubMed]
202. Dutertre, M.; Sanchez, G.; Barbier, J.; Corcos, L.; Auboeuf, D. The emerging role of pre-messenger RNA
splicing in stress responses: Sending alternative messages and silent messengers. RNA Biol. 2011, 8, 740–747.
[CrossRef] [PubMed]
203. Giono, L.E.; Nieto Moreno, N.; Cambindo Botto, A.E.; Dujardin, G.; Munoz, M.J.; Kornblihtt, A.R. The RNA
Response to DNA Damage. J. Mol. Biol. 2016, 428, 2636–2651. [CrossRef] [PubMed]
204. Bartel, F.; Taubert, H.; Harris, L.C. Alternative and aberrant splicing of MDM2 mRNA in human cancer.
Cancer Cell 2002, 2, 9–15. [CrossRef]
205. Chandler, D.S.; Singh, R.K.; Caldwell, L.C.; Bitler, J.L.; Lozano, G. Genotoxic stress induces coordinately
regulated alternative splicing of the p53 modulators MDM2 and MDM4. Cancer Res. 2006, 66, 9502–9508.
[CrossRef] [PubMed]
206. Jeyaraj, S.; O’Brien, D.M.; Chandler, D.S. MDM2 and MDM4 splicing: An integral part of the cancer spliceome.
Front. Biosci. 2009, 14, 2647–2656. [CrossRef]
207. Okoro, D.R.; Rosso, M.; Bargonetti, J. Splicing up mdm2 for cancer proteome diversity. Genes Cancer 2012, 3,
311–319. [CrossRef] [PubMed]
208. Jones, S.N.; Hancock, A.R.; Vogel, H.; Donehower, L.A.; Bradley, A. Overexpression of Mdm2 in mice reveals
a p53-independent role for Mdm2 in tumorigenesis. Proc. Natl. Acad. Sci. USA 1998, 95, 15608–15612.
[CrossRef] [PubMed]
209. Matsumoto, R.; Tada, M.; Nozaki, M.; Zhang, C.L.; Sawamura, Y.; Abe, H. Short alternative splice transcripts
of the mdm2 oncogene correlate to malignancy in human astrocytic neoplasms. Cancer Res. 1998, 58, 609–613.
[PubMed]
210. Naro, C.; Bielli, P.; Pagliarini, V.; Sette, C. The interplay between DNA damage response and RNA processing:
the unexpected role of splicing factors as gatekeepers of genome stability. Front. Genet. 2015, 6, 142.
[CrossRef] [PubMed]
211. Montecucco, A.; Biamonti, G. Pre-mRNA processing factors meet the DNA damage response. Front. Genet.
2013, 4, 102. [CrossRef] [PubMed]
212. Lambeth, J.D.; Neish, A.S. Nox enzymes and new thinking on reactive oxygen: A double-edged sword
revisited. Annu. Rev. Pathol. 2014, 9, 119–145. [CrossRef] [PubMed]
213. Bedard, K.; Krause, K.H. The NOX family of ROS-generating NADPH oxidases: Physiology and
pathophysiology. Physiol. Rev. 2007, 87, 245–313. [CrossRef] [PubMed]
214. Lambeth, J.D.; Kawahara, T.; Diebold, B. Regulation of Nox and Duox enzymatic activity and expression.
Free Radic. Biol. Med. 2007, 43, 319–331. [CrossRef]
215. Brown, D.I.; Griendling, K.K. Regulation of signal transduction by reactive oxygen species in the
cardiovascular system. Circ. Res. 2015, 116, 531–549. [CrossRef]
216. Valko, M.; Leibfritz, D.; Moncol, J.; Cronin, M.T.; Mazur, M.; Telser, J. Free radicals and antioxidants in normal
physiological functions and human disease. Int J. Biochem. Cell Biol. 2007, 39, 44–84. [CrossRef]
217. Lambeth, J.D. Nox enzymes, ROS, and chronic disease: An example of antagonistic pleiotropy. Free Radic.
Biol. Med. 2007, 43, 332–347. [CrossRef]
218. Nisimoto, Y.; Diebold, B.A.; Cosentino-Gomes, D.; Lambeth, J.D. Nox4: A hydrogen peroxide-generating
oxygen sensor. Biochemistry 2014, 53, 5111–5120. [CrossRef] [PubMed]
219. Lassegue, B.; Griendling, K.K. NADPH Oxidases: Functions and Pathologies in the Vasculature. Arterioscler.
Thromb. Vasc. Biol. 2010, 30, 653–661. [CrossRef] [PubMed]
220. Lyle, A.N.; Deshpande, N.N.; Taniyama, Y.; Seidel-Rogol, B.; Pounkova, L.; Du, P.; Papaharalambus, C.;
Lassegue, B.; Griendling, K.K. Poldip2, a novel regulator of Nox4 and cytoskeletal integrity in vascular
smooth muscle cells. Circ. Res. 2009, 105, 249–259. [CrossRef] [PubMed]

Genes 2017, 8, 190

30 of 30

221. Datla, S.R.; McGrail, D.J.; Vukelic, S.; Huff, L.P.; Lyle, A.N.; Pounkova, L.; Lee, M.; Seidel-Rogol, B.;
Khalil, M.K.; Hilenski, L.L.; et al. Poldip2 controls vascular smooth muscle cell migration by regulating
focal adhesion turnover and force polarization. Am. J. Physiol. Heart Circ. Physiol. 2014, 307, H945–H957.
[CrossRef] [PubMed]
222. Sutliff, R.L.; Hilenski, L.L.; Amanso, A.M.; Parastatidis, I.; Dikalova, A.E.; Hansen, L.; Datla, S.R.; Long, J.S.;
El-Ali, A.M.; Joseph, G.; et al. Polymerase Delta Interacting Protein 2 Sustains Vascular Structure and
Function. Arterioscler. Thromb. Vasc. Biol. 2013, 33, 2154–2161. [CrossRef] [PubMed]
223. Brown, D.I.; Lassegue, B.; Lee, M.; Zafari, R.; Long, J.S.; Saavedra, H.I.; Griendling, K.K. Poldip2 knockout
results in perinatal lethality, reduced cellular growth and increased autophagy of mouse embryonic
fibroblasts. PLoS ONE 2014, 9, e96657. [CrossRef] [PubMed]
© 2017 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).

